Search this site

Minnesota OCM can deny or block a cannabis-license investment when an investor is an owner, manager, officer, director, general partner, controlling person, or other person responsible for the business. That person fails the criminal, regulatory, ownership, or disclosure requirements. The most serious criminal disqualifiers are specified drug-trafficking offenses, human or labor trafficking, fraud and financial crimes, certain cannabis-sale convictions after August 1, 2023, adulteration, and electronic-data theft; a disqualifying felony is permanent unless OCM grants a variance. A person who merely makes a properly structured passive investment may be excluded from the statutory definition of “true party of interest,” but that exclusion should not be treated as automatic protection from review. Minnesota’s background-check statute and rule broadly reach owners and people responsible for conducting the entity’s affairs, while OCM also requires disclosure of investment sources and true parties of interest. People OCM Reviews The criminal-history requirement reaches every cannabis-license applicant or holder and, for a business entity, every person responsible for conducting its affairs, including owners, cooperative members or directors, managers, and general partners. State and national records may be checked through the BCA and FBI. Every officer, director, manager, and general partner must also satisfy the general ownership qualifications in Minnesota Statutes section 342.16. These include being at least 21, not being an OCM or relevant state-agency employee, not being a licensed peace officer, not having a Minnesota or out-of-state cannabis authorization revoked, complying with cannabis tax and OCM information requests, and having no recent confirmed willful labor violation covered by the statute. Criminal Disqualifiers Category Conduct covered Normal effect Serious noncannabis drug offenses First- or second-degree controlled-substance crimes; possession of substances with intent to manufacture methamphetamine; counterfeit drugs; causing great bodily harm through drug distribution; using drugs to injure or facilitate crime; and sale of cannabis to a minor Disqualifying; permanent if the offense is a felony, subject to a variance. Trafficking Labor trafficking; sex trafficking and promotion-related offenses; trafficking-related document offenses Disqualifying; permanent if felony, subject to variance. Fraud and financial crimes False tax statement, bribery, perjury, concealing criminal proceeds, insurance fraud, theft of public funds, false government claims, medical-assistance fraud, forged instruments, specified notary and lottery fraud, commercial bribery, and any crime having fraud, deceit, or embezzlement as a required element Disqualifying; permanent if felony, subject to variance. Post-legalization cannabis sales Cannabis-sale crimes under section 152.0264 for convictions after August 1, 2023 Five years from conviction under Rule 9810.1001. Other offenses Adulteration and computer or electronic-data theft Disqualifying; permanent if felony, subject to variance. Attempts and conspiracies Attempting or conspiring to commit one of the listed crimes Treated as disqualifying when the underlying crime is listed. Equivalent federal/out-of-state crimes Conviction whose elements match a listed Minnesota crime Treated as disqualifying. Not every felony is automatically disqualifying merely because it is a felony. Rule 9810.1001 supplies the operative offense list, although its catchall for an offense in which fraud, deceit, or embezzlement is a necessary element can capture crimes bearing different titles in Minnesota or elsewhere. A violation of Minnesota Statutes section 152.025 cannot be made disqualifying under section 342.15. Certain successfully completed stays of adjudication and an eligible expunged conviction under former section 152.09 are also excluded by the rule. Variance Possibility A permanent felony disqualification is not necessarily the final word. After at least five years from release from incarceration or conviction, whichever is later, the person may ask OCM to make the disqualification nonpermanent by showing that permanence does not serve the public interest. OCM’s factors include the proposed role, seriousness and circumstances of the crime, age at the time, whether it was isolated, rehabilitation, conduct in custody or the community, treatment or education, recommendations from supervisors or mentors, and community benefit from licensing the applicant. Noncriminal Barriers OCM may also disqualify based on a substantiated civil or regulatory violation that creates a public-health or safety risk. A prior disqualification, revocation, or prohibition imposed by another state’s cannabis authority is independently disqualifying under the rule.revisor.mn An unlicensed chapter 342 violation followed by an OCM administrative order after August 1, 2023 carries a five-year disqualification from the order date under the rule. Current statutory requirements also bar an applicant whose Minnesota or out-of-state cannabis authorization was previously revoked. Investor Structures A true party of interest generally includes LLC members and managers, partners, privately held corporate stockholders, officers and directors, people in layered ownership structures, anyone entitled to cannabis-business revenue or profit, and anyone with control. All true parties must be disclosed, and the business must disclose the source of invested money before investment. A passive ownership interest meeting the federal passive-investment definition is excluded from “true party of interest.” Fixed-rent landlords, ordinary salaried employees without ownership or control, qualifying consultants and service providers, and financial institutions are also excluded, but a lender expecting repayment may be a “financier” whose funding source still must be disclosed. A financier cannot take ownership, control, revenue, gross-profit or net-profit participation, or another profit-sharing right in return for funding unless the directly involved financier is disclosed to OCM as a true party of interest. Attempts to label equity, control, or profit participation as a “loan” will therefore not avoid disclosure. Other barred investors A licensed peace officer an OCM employee an employee of another state agency regulating chapter 342 cannot qualify in the roles governed by section 342.16. A health-care practitioner who certifies patients’ qualifying medical conditions cannot hold a direct or indirect economic interest in a cannabis business or serve as its cooperative member, director, manager, general partner, or employee. OCM can also reject ownership changes that add an owner who is ineligible under the background-check process, violate true-party-of-interest provisions, or reduce required social-equity ownership below 65% where that restriction applies. Ownership or control changes and license transfers require prior OCM review in the circumstances described by OCM. Practical Underwriting Before accepting funds, obtain the investor’s complete criminal history from every jurisdiction, cannabis-license and regulatory history, civil-enforcement history, labor-compliance history, ownership in other cannabis applicants or licenses, intended economic rights, source of funds, and proposed management powers. Compare the exact statute of conviction—not merely the crime’s common name—to Rule 9810.1001, because federal and out-of-state offenses turn on matching elements. The investment documents, capitalization table, operating agreement, promissory note, security agreement, profit rights, veto rights, and side letters should all tell the same story. OCM requires continuing disclosure of true parties and invested-money sources, and materially false or omitted application information can itself support denial. This report addresses Minnesota adult-use cannabis-business licensing, not legal advice for a specific investor. Hemp-business applicants are treated differently because section 342.15’s background checks and disqualifications do not apply to hemp-business applicants or hemp workers

You request it from the Minnesota Office of Cannabis Management through your preliminary license record in Accela. Under the current law, your first extension—up to six months—must be granted upon request; a possible second extension of up to six months is discretionary and requires proof that you have made good-faith efforts to convert the preliminary approval into a full license. Current extension timeline Stage Time available Standard Preliminary approval 18 months Complete all final licensing requirements before expiration Initial extension Up to 6 months OCM must grant it when you request it Additional extension Up to 6 months OCM may grant it if you show good-faith progress toward licensure That provides up to 30 months total from preliminary approval if OCM approves the additional, good-faith extension. An expired preliminary approval cannot be converted into a cannabis business license, so submit the request well before the deadline. How to request it Check your preliminary-approval expiration date in your OCM/Accela record and identify the date that falls 60–90 days beforehand. Watch the email addresses associated with the application, including spam and junk folders. OCM has stated it will email preliminary-approval holders approximately 60 days before expiration with instructions for requesting an extension. The notice is expected to come from noreply@accela.com.mn Log in to Accela using the account tied to the preliminary approval. Look for an extension-related task, notification, or request option within the license/application record. Accela is OCM’s platform for submitting and updating information, paying fees, scheduling inspections, monitoring status, and printing license records. Submit the extension request before the preliminary approval expires. For your initial six-month extension, make a clear written request and retain a PDF or screenshot of the submission confirmation. If you may need a second extension, build the record now. The statute makes this one dependent on good-faith efforts, so prepare evidence rather than relying on a narrative alone. What to document Even if the first extension is mandatory upon request, a short, organized progress package can reduce questions and protect you if you later need the additional extension. Include: Accela application/license number, legal entity name, license type, and original preliminary-approval date. Facility address or your active site-selection status. Local zoning correspondence, zoning verification, conditional-use permit materials, or local registration documentation. Executed lease, purchase agreement, landlord letter, LOI, or explanation of a documented site contingency. Construction drawings, architect/engineer agreements, permit applications, bids, contractor schedules, and equipment orders. Final Plans of Record progress, including security plans, SOPs, floor plans, inventory controls, and operational-readiness documents. Evidence of completed or pending background checks and required ownership disclosures. Financing documentation showing capital raised, lender diligence, investor activity, or a buildout budget and timeline. A dated milestone schedule showing exactly what will be completed during the requested extension period. Documentation of delays outside your control, such as municipal review, permitting, utility upgrades, landlord construction, lender timelines, or OCM-requested revisions. Sample Request Language Subject: Request for Initial Extension of Preliminary License Approval — [Legal Entity Name] / [Accela Record Number] To the Minnesota Office of Cannabis Management: [Legal Entity Name], holder of preliminary license approval for a [license type], respectfully requests an initial extension of its preliminary license approval for up to six months under Minnesota Statutes, section 342.14.Our preliminary approval expires on [date]. We remain actively engaged in completing all requirements necessary to convert the preliminary approval into an operating cannabis business license. Current progress includes [brief list: site control/zoning, plan development, financing, permitting, construction, final-plan preparation, etc.]. During the extension period, we expect to complete the following milestones: [list the remaining steps and target dates]. Please confirm receipt and approval of this request through Accela or the contact information below. Sincerely, [Name] [Title] [Legal Entity Name] [Accela Record Number] [Email] | [Phone] Important distinction Do not confuse this with annual license renewal. An extension applies while you hold preliminary approval and are trying to obtain your initial operating license. Once the full license is issued, OCM requires annual renewal through Accela, with the renewal application generally made available 90 days before expiration.mn If you have not received OCM’s 60-day email and are within roughly 75 days of expiration, submit an inquiry through your Accela record or contact OCM promptly—do not wait for the expiration date.

Need to gain Social Equity Status? Minnesota Office of Cannabis Management now allows SEA approvals (typically takes 2-3 business days currently)? Visit Qualifications / Office of Cannabis Management. For the OCM programs, visit mn.gov/ocm/businesses/grants, and for DEED programs, visit mn.gov/deed. Office of Cannabis Management (OCM) Grant Programs - LINK CanGrow (OCM-SEA approved status) — Currently Open Primarily focused on farmers/cultivators, so it has limited direct relevance to other licenses such as Manufacturing/Wholesale/Transport/Delivery licenses. However, if you have any cultivation component or are working with farming partners, this may apply. Technical assistance grants: $10,000–$50,000 for training and education Farmer loan financing: $2,500–$50,000 per individual (up to $150,000 with matching funds) Current deadline: June 1, 2026 at 4:30pm CST. Applications go through OCM's online portal CanRenew (OCM-SEA approved status) — Next Round TBD (Mid to Late 2026) Provides community restoration grants in areas disproportionately impacted by cannabis prohibition. Important caveat: CanRenew funds cannot be used for cannabis business operations or revenue-generating activities — it funds community-oriented projects (economic development, youth programs, violence prevention, civil legal aid). FY2026 allocation: $10.9 million total Tier 1: $2,500–$10,000 for smaller/newer organizations Tier 2: $50,000–$2,000,000 for larger projects The FY2026 application window was Nov. 2025 – Jan. 12, 2026 (now closed); watch for the FY2027 cycle updates (mid to late 2026). Minnesota Department of Employment and Economic Development (DEED) Grant & Loan Programs - LINK CanNavigate (DEED) — Active, Service Providers Selected DEED partnered with community-based organizations to provide free technical assistance to cannabis entrepreneurs navigating OCM's regulatory structure. As an SEA, you can access services from a CanNavigate provider (rather than apply as a provider yourself) at no cost. Total program funding: $2 million Priority is given to SEAs and disproportionately impacted communities Contact DEED or OCM to be connected with a local CanNavigate partner organization CanStartUp (DEED) — Active Loan Program This is one of the most directly relevant programs for you. DEED awards grants to nonprofit lenders, who then make loans to new cannabis microbusinesses, with priority given to SEAs. Program funding: $6 million allocated Priority given to social equity applicants. Limitation: Technically written for microbusinesses — consult DEED to confirm eligibility for other license types Access through DEED-selected nonprofit lenders, not directly from DEED CanTrain (DEED) — Workforce Development Grants to organizations providing cannabis workforce training. Directly relevant if you need to hire and train staff. Grants up to $500,000 per organization Next deadline listed as December 2, 2026 You would work with a CanTrain-funded organization for workforce development DEED Veteran-Specific Programs Reservist and Veteran Business Loan Program - LINK Specifically designed for veterans starting businesses. Directly relevant to you as a veteran SEA. Interest-free loans of $5,000–$20,000 For veterans who were on active duty on or after September 11, 2001 Must have separated under honorable conditions after 181+ consecutive days of active duty Apply through DEED directly Emerging Entrepreneur Loan Program (ELP) - LINK One of the most flexible programs for veteran-owned businesses. Loans of $5,000–$150,000 for businesses at least 51% owned by a veteran (among other qualifying categories) Can fund startup costs, equipment, inventory, working capital, renovation, and site acquisition DEED provides funds through certified nonprofit lenders statewide Interest rates capped (not to exceed 4% over Wall Street prime) Available through lenders like Southern Minnesota Initiative Foundation, RAEDI, and others. What's Not Available to You SBA/USDA federal loans are unavailable for state-legal cannabis businesses due to federal prohibition — these apply only to hemp businesses with under 0.3% THC. Iron Range Resources (IRRRB) loans explicitly exclude transportation and retail cannabis operations from eligibility. Minnesota Department of Revenue does not offer grants for cannabis businesses; their cannabis-related programs focus on local government aid, which was actually repealed by the 2025 Legislature. Recommended Action Plan Grant Priority Program What to Do Immediate CanGrow Apply by June 1, 2026 if you have a farming/cultivation angle. Now CanNavigate Contact DEED to connect with a free CanNavigate service provider for regulatory guidance. Now Veteran Business Loan Apply through DEED for 0% interest startup loan up to $20,000. Now ELP (Emerging Entrepreneur Loan Program) Apply through a certified nonprofit lender for up to $150,000. Ongoing CanStartUp Work with a DEED-selected nonprofit lender for microbusiness loan access. FY2027 Late CanRenew Watch OCM for the next application cycle (community-focused projects only). Need help navigating the grant process? Reach out to us at info@carpfishcreative.com.

Any cannabis retailer (or microbusiness/mezzobusiness/macrobusiness with a retail operations endorsement) that wants to sell medical cannabis to registered patients must obtain a medical cannabis retail endorsement from the Office of Cannabis Management (OCM), which is separate from your base retail license. Statutory Requirements Under Minnesota Statutes section 342.51, OCM must issue the endorsement if you meet three conditions: Submit a medical cannabis retail endorsement application to OCM Employ at least one person who has earned a medical cannabis consultant certificate through OCM's required training, OR employ at least one person who is a licensed pharmacist under Minnesota Statutes chapter 151 Meet all other applicable requirements OCM establishes Once granted, the endorsement lets you purchase medical cannabis flower and medical cannabinoid products from businesses holding medical cultivator or processor endorsements, and sell those products to registered patients, caregivers, parents, guardians, or spouses. You'll also need to verify that all medical products have passed safety, potency, and consistency testing at an OCM-approved testing facility before distributing it. Application Process Since you already hold or are pursuing a retail license, adding the endorsement is done through an amendment process rather than a brand-new application: Submit a new site registration in Accela and upload an amended final plan of record focused specifically on the medical endorsement/activity you're adding Email ocm.licensing@state.mn.us to notify OCM that Accela has been updated with the proposed changes OCM reviews the application, and your local jurisdiction must also approve the amended site registration OCM conducts inspection/review and notifies you of approval or denial This applies broadly — the OCM's June 2026 compliance bulletin confirms microbusinesses, mezzobusinesses, and retailers can all apply for the medical retail endorsement through this same Accela-based process. Important Timing and Structural Notes Consideration Detail Separate supply chains Until Jan 1, 2027, medical and adult-use cannabis remain legally distinct; a business endorsed for both must maintain separate supply chains for each 2027 merger The 2026 legislative session passed changes to streamline/merge medical and adult-use supply chains, effective Jan 1, 2027 Medical Combination businesses If you're a medical cannabis combination business rather than a standard retailer, you're exempt from needing this endorsement — you're already authorized to sell medical cannabis at your retail locations by statute High medical need areas Pending legislation (S.F. 4401) would let retailers with a medical retail endorsement operate up to three additional retail locations beyond normal limits if located in an OCM-designated "high medical need area" Local approval Local government zoning/registration approval is still required regardless of endorsement type 💡Staffing Requirement — the Practical Bottleneck The consultant certificate/pharmacist requirement is usually the pacing item for operators. Since you're building consulting/compliance capacity, budgeting time for at least one staff member to complete OCM's medical cannabis consultant training and certification (or hiring/contracting a licensed pharmacist) should happen in parallel with the Accela site-registration amendment, so staffing isn't the bottleneck once your amended plan of record and local approval are ready. If you have multiple retail locations, note that each location's amendment for the endorsement is evaluated individually, and OCM's pre-license inspection list for medical-related activities is being kept current on their "Preparing to Open" resources page. Medical Cannabis Consultant Training Programs OCM is tasked with developing and maintaining the certified medical cannabis consultant (CMCC) program. CMCCs are specialists trained to provide patients with expert, accurate information about medical cannabis. Their role is to fill a critical gap in the medical system, as traditional professional programs often do not cover this topic in depth. A cannabis business authorized to sell medical cannabis to registered medical cannabis patients must employ either a pharmacist or a CMCC to have availability for patient consultations. A CMCC is only permitted to perform their role while employed by a licensed medical cannabis retailer. By integrating CMCCs into the medical cannabis market, patient access to reliable advice is significantly improved. This approach expands the network of qualified professionals beyond the limited number of pharmacists, ensuring more patients receive specialized guidance tailored to their specific needs. Ultimately, the use of CMCCs enhances patient care and knowledge. Curricula for Certified Medical Cannabis Consultant Training Programs In developing the CMCC program, OCM must approve training programs for CMCCs. OCM developed a document outlining OCM’s requirements for CMCC training program curricula, as defined in Minnesota law. OCM asked organizations to submit CMCC training curricula using this guidance. Certified Medical Cannabis Consultant: Training Program Submission Guidance (PDF) Approved training programs Training Program Contact Email Website Expiration Date Lauryn House LLC cmcc@laurynhouse.com laurynhouse.com March 20, 2029 MM411 help@medicalmarijuana411.com mm411.com March 27, 2029 Green CulturED info@greencultured.co greencultured.co March 27, 2029

On June 16, 2026, Governor Abigail Spanberger, Senate patron Sen. Lashrecse Aird (D-Petersburg), and House patron Del. Paul Krizek (D-Fairfax) jointly announced a new budget compromise proposal to establish Virginia's legal retail cannabis market. The deal emerged after years of legislative battles, a prior veto, and a looming June 30 state budget deadline. Rather than standing as standalone legislation, the cannabis framework is embedded within Virginia's broader state budget bill, which must pass both chambers and be signed by the governor before the June 30 deadline to avoid a government shutdown.[1][2][^3] The compromise resolves key conflicts between Spanberger's earlier vetoed substitute bill and the original HB 642/SB 542 framework passed by the General Assembly in March 2026. As of the announcement date, the full legislative text had not yet been made public, but the parties released detailed term sheets and held a joint press conference.[4][2][3][5] Background: Legislative History Leading to June 16 Understanding the June 16 compromise requires context on the steps that preceded it: 2021: Virginia legalized adult possession (up to 1 oz) and home cultivation (4 plants/household), but retail sales were never implemented.[6][7] January 2026: HB 642 (Del. Krizek) and SB 542 (Sen. Aird) introduced to establish a retail framework.[8][6] February–March 2026: Both chambers passed their respective bills; a conference committee produced a unified compromise bill; the General Assembly passed it 64-32 (House) and 21-18 (Senate) and sent it to Spanberger.[9][10] April 2026: Gov. Spanberger returned the bills with sweeping amendments — pushing the launch to July 1, 2027, cutting the retail cap to 200, and adding harsher criminal penalties. The General Assembly rejected these changes on April 22 and returned the original bill unchanged.[11][12][13][14] May 19, 2026: Gov. Spanberger vetoed both HB 642 and SB 542, sending shockwaves through the industry.[15][4] Early June 2026: Lawmakers and the governor entered renewed negotiations, framing the budget bill as the last viable vehicle to get a framework enacted before potential delays pushed legal sales to 2028 or later.[16][17] June 15–16, 2026: The tri-party compromise was announced at a joint press conference at the Patrick Henry Building in Richmond.[3][1] Complete Listing of June 16, 2026 Compromise Provisions 1. Retail Launch Date Retail sales begin: July 1, 2027[1][3] This is the central change from the March 2026 bill (which set January 1, 2027) and reflects the governor's previously stated need for more time for the Cannabis Control Authority (CCA) to "develop regulations, establish testing and safety standards, and build the necessary oversight framework"[^3] The six-month delay from the vetoed bill's January 2027 date is the primary concession by legislative Democrats[^3] 2. Possession Limit Possession limit increases from 1 ounce to 2 ounces[1][3] This is a reduction from the 2.5-ounce limit in the original HB 642/SB 542 bills[13][9] It aligns with the governor's earlier proposed substitute, which also called for a 2-ounce limit[^13] Home cultivation of up to four plants per household remains legal under prior 2021 law[^7] 3. Taxation Structure State Cannabis Excise Tax 6% state cannabis excise tax at launch (July 1, 2027)[1][3] Increases to 8% after July 1, 2029 — a two-year grace period designed to help the legal market establish itself and compete against the illicit market[3][1] Gov. Spanberger cited tax models from other states as the basis for the tiered structure[^1] Local Tax Option Localities may impose an additional 1% to 3.5% local tax[3][1] Localities cannot opt out of allowing cannabis businesses to operate[9][3] Combined Tax Rates Combined with the existing state retail sales tax (base rate of 5.3%), the total initial tax rate is estimated at 12.3% to 14.8%[^1] After July 2029, the combined rate would rise to approximately 14.3% to 16.8% Revenue Allocation Tax revenues are allocated to the following purposes:[3][1] Early childcare and education K-12 education Behavioral health programming for substance use disorder prevention and treatment Public health programs The Cannabis Equity Reinvestment Fund The Cannabis Equity Reinvestment Fund — established in 2021 legislation — supports scholarships, workforce development, small business growth, reentry services, and community-based initiatives for communities disproportionately affected by cannabis enforcement.[^3] 4. Licensing Structure & Caps License Application Timeline CCA begins accepting applications: February 1, 2027[1][3] This is a substantial shift from the previous bill, which had the CCA opening applications in fall 2026[18][19] Retail License Cap Maximum of 350 retail cannabis establishment licenses statewide[1][3] Licenses will be phased in based on demand and geographic balance as determined by the CCA — not issued all at once[^1] The cap remains at 350 until at least January 1, 2028, after which the CCA may expand the market[20][19] At least 50% of new licenses must be awarded to impact applicants (social equity)[19][20] License Types The compromise preserves the full suite of license types authorized under the prior framework:[21][22] License Type Key Details Retail Marijuana Store Capped at 350 statewide; phased rollout; 1,000-ft setback from schools, hospitals, playgrounds, drug treatment facilities[3][19] Microbusiness License Vertically integrated (cultivation + processing + retail); up to 100 licenses issued by May 1, 2027; up to 2 locations per licensee within 10 miles[1][23] Marijuana Cultivation Facility (Tier I–V) Tiered by canopy size; Tier V capped at 35,000 sq ft; no Tier V licenses until after Jan. 1, 2028; up to 450 total cultivation licenses statewide[24][19] Marijuana Processing Facility Up to 60 processing licenses statewide[^24] Marijuana Testing Facility Independent third-party product testing[21][22] Marijuana Transporter License Regulated transportation between licensed facilities[21][22] Marijuana Delivery Operator Permitted delivery services to consumers[21][20] Dual-Use Facility License Existing medical cannabis operators (pharmaceutical processors) converting to adult-use; $10 million one-time conversion fee; canopy capped at 70,000 sq ft indoor[9][25] Nursery Cultivation License Small growers cultivating seeds, clones, and immature plants[^26] Ownership & License Stacking Limits No individual or entity may hold more than 5 total licenses (excluding transporter licenses)[22][19] No more than 1 Tier V cultivation license per entity[22][19] Microbusiness licensees cannot hold any additional marijuana licenses[^22] 5. Microbusiness Provisions The June 16 compromise restores several microbusiness provisions that had been stripped in prior negotiations:[^27] Up to 100 microbusiness licenses may be issued by May 1, 2027[27][1] Each microbusiness may operate up to two locations under their license, providing flexibility for small operators[27][1] Microbusinesses are vertically integrated — they may cultivate, process, and sell directly to consumers[28][21] Indoor canopy cap: 5,000 sq ft; outdoor canopy cap: 10,000 sq ft[21][22] Microbusinesses receive priority in early licensing alongside impact applicants[^29] 6. Impact License (Social Equity) Provisions The compromise preserves the full Impact License framework with significant equity funding restored:[27][1] Eligibility Criteria An applicant must meet the majority ownership threshold and at least one of several qualifying criteria, which may include:[30][29] Prior residence in a disproportionately impacted area (1999–2025) Residence in a historically economically disadvantaged community for 3 of the last 5 years Prior cannabis-related conviction or adjudication Other criteria (agricultural/economic disadvantage, geographic inequity) Anti-Predatory Protections Five-year holding period for impact licenses — they cannot be sold or transferred for 5 years after issuance[27][1] Limits on ownership transfers and strict anti-assignment rules[27][1] License revocation tools if licenses are transferred in prohibited ways[^27] Ownership transparency: all beneficial owners must be disclosed to the CCA[^31] Equity Funding 75% of first-year license fee revenue deposited into the Cannabis Equity Business Loan Fund within 60 days of receipt[29][27][^1] The fund provides grants, low-interest loans, and zero-interest loans to qualified equity/microbusiness applicants[32][29] A Cannabis Impact Business Support Team will be created to provide technical assistance, guidance, and regulatory navigation support to impact-licensed entrepreneurs[27][1] 7. Enforcement & Criminal Penalties The June 16 compromise drops the most controversial criminal penalty provisions that Spanberger had previously demanded:[2][1] Transport Penalties — DROPPED Controversial "transport penalties" that critics compared to second-degree homicide charges have been removed[^1] Enforcement focus shifts toward protecting young people — specifically illegal sales to minors — rather than extreme penalties for transporting cannabis[^1] Public Consumption Penalty $250 civil fine for public cannabis consumption[2][1] Delayed until July 2027 to allow time to assess potential disproportionate enforcement impacts[2][1] Advocates expressed concern about racially disparate enforcement; Sen. Aird noted the delay gives lawmakers an opportunity to reassess or revise the penalty before it takes effect[^2] The penalty is civil, not criminal — comparable to a red-light ticket[^2] Unlicensed Sales Penalties (From Prior Framework) Under the original HB 642/SB 542 that this compromise builds upon:[6][9] 1st offense (no license, selling/distributing): Class 2 misdemeanor 2nd offense: Class 1 misdemeanor Subsequent offenses: Class 6 felony Unlicensed cultivation: Class 6 felony Selling to minors: Class 1 misdemeanor (remains unchanged) Youth Protections (Strengthened) Prohibitions on cartoon advertisements targeting minors[^3] Requirements for child-safe packaging[^3] Prohibition on products shaped like animals, fruits, vehicles, or humans[^3] Escalating CCA penalties for failed ID checks, up to license revocation for repeated underage sales[^3] Retail stores must be no less than 1,000 feet from schools, hospitals, playgrounds, and drug treatment facilities[19][3] 8. Hemp Regulation The compromise ends the 25:1 hemp loophole (the CBD-to-THC ratio exemption that previously allowed hemp products to exceed the 2 mg THC package cap)[33][3] Regulation of industrial intoxicating hemp transfers from the Virginia Department of Agriculture and Consumer Services (VDACS) to the CCA[9][3] Hemp products sold outside licensed cannabis stores will be subject to strict testing, labeling, and safety regulations[1][3] The 2 mg THC-per-package limit on hemp products remains in effect[34][33] 9. Regulatory Infrastructure & Oversight The Virginia Cannabis Control Authority (CCA) continues as the sole oversight body for licensing, enforcement, and regulation[3][1] CCA authorized to maintain a public licensee registry, including ownership and financial details[26][3] CCA may establish a tip line for anonymous public reporting of illicit practices[^3] CCA may investigate ownership and control interests of licensees[^3] CCA may develop policies for auditing financial relationships across licensees[^3] Seed-to-sale tracking is preserved[27][1] Mandatory product testing, labeling, and QR code links to lab results required[20][1] Labor peace agreements required for cannabis businesses[^35] Serving sizes limited to 10 mg THC per serving; maximum 100 mg THC per package[36][35] 10. Medical Cannabis Operators (Pharmaceutical Processors) Existing medical cannabis operators (pharmaceutical processors) may convert to dual-use licenses to serve the adult-use market[25][9] $10 million one-time conversion fee per location (up to the licensed number of locations)[4][25][^9] Dual-use cultivators are limited to indoor cultivation only, including in secure greenhouses[37][23] Cultivation canopy capped at 70,000 sq ft for dual-use operators[37][25] Dual-use operators cannot hold additional marijuana licenses beyond their medical permits[23][37] Conversion fee may be paid in installments under terms set by the CCA[^37] 11. Local Government Rules No opt-outs: Localities cannot prohibit cannabis businesses from operating in their jurisdiction[9][1] Localities retain control over time, place, and manner restrictions[^38] Localities may impose a local cannabis tax of 1% to 3.5%[1][3] All retail and microbusiness locations subject to 1,000-foot setback requirements from schools, hospitals, playgrounds, and drug treatment facilities[19][3] Tribal governments: Sovereign rights to regulate cannabis are respected; the state may enter into compacts with tribal governments[^20] 12. Hemp Licensing (Retail) Retail hemp sales regulated under the CCA framework[^20] Annual retail hemp license fee: $1,000[^20] Hemp products capped at 2 mg THC per package[33][20] 13. Studies & Future Actions Directed The compromise directs further study or future legislative action on several topics:[20][27] On-site consumption licenses (cannabis lounges/cafes) Microbusiness event permits (e.g., farmers market or pop-up sales) Potential role of the Virginia Alcoholic Beverage Control Authority (ABC) in cannabis regulation or enforcement Impact license fund allocation rules will be finalized in the 2027 legislative session[^1] Study of cannabis education requirements in schools[^3] 14. Resentencing / Prior Convictions (Related Legislation) A separate but related measure, HB 26/SB 62, establishes a resentencing and hearing process for individuals still incarcerated for past cannabis offenses that are no longer chargeable. The governor had previously proposed amendments to remove automatic resentencing deadlines; the final compromise on this provision was not fully detailed in the June 16 announcement, and it remains a companion effort to the budget cannabis framework.[^39] Key Changes: June 16 Compromise vs. Prior Bills Provision Original HB 642/SB 542 (March 2026) Gov. Substitute (April 2026, Vetoed) June 16 Compromise Retail launch date Jan. 1, 2027 July 1, 2027 July 1, 2027 Possession limit 2.5 oz 2 oz 2 oz State cannabis tax 6% flat 6% → 8% after 2029 6% → 8% after July 1, 2029 Retail license cap 350 200 (until 2029) 350 (phased rollout) Microbusiness licenses 100 by Oct. 1, 2026 Not preserved 100 by May 1, 2027 CCA application opening Sep.–Dec. 2026 Sep. 2026 Feb. 1, 2027 Transport penalties Moderate Severe (homicide-linked) Dropped Public consumption No penalty Criminal $250 civil fine, delayed to 2027 Equity fund (license fees) 75% of first-year fees Eliminated 75% of first-year fees restored 5-yr impact license hold Yes Stripped Restored Hemp 25:1 loophole Closed Closed Closed Hemp regulatory body Transferred to CCA Transferred to CCA Transferred to CCA Status & Next Steps The cannabis provisions in the June 16 compromise are embedded in Virginia's state budget bill. For the framework to take effect:[2][3] Budget agreement required — The Senate was scheduled to vote on June 22, ahead of a June 30 budget deadline. If the budget lapses, a government shutdown occurs and cannabis provisions would be delayed.[2][3] CCA regulation drafting — The CCA must develop implementing regulations before accepting applications on February 1, 2027.[^3] License applications open: February 1, 2027[^3] Up to 100 microbusiness licenses issued by: May 1, 2027[27][1] Retail sales begin: July 1, 2027[1][3] As of the June 16 announcement, the full legislative text of the budget provision had not yet been released publicly.[^2] References Virginia leaders reach marijuana compromise; retail sales ... - The compromise sets a 6% starting tax, phases in 350 licenses, and directs funding to help small and... Virginia's marijuana market compromise leaves advocates ... - WVTF - And while advocates are generally pleased with the final version of the effort, including rolling ba... Gov. Spanberger, Virginia lawmakers reveal retail cannabis market ... - Spanberger, Virginia lawmakers reveal retail cannabis market compromise, sales to begin July 2027 ..... Virginia Governor Vetoes Recreational Cannabis Bills - Five years after Virginia became the first state in the South to legalize adult-use cannabis possess... Spanberger vetoes Virginia cannabis retail bill - Outlaw Report - An unlicensed D.C. storefront gets permanently shuttered, $60M in institutional capital enters canna... Virginia Committee Votes 19 to 2 to Legalize Recreational Cannabis ... - Legislation to create a regulated recreational marijuana market in Virginia (House Bill 642) was giv... Cannabis in Virginia - Wikipedia Virginia bill sets earliest cannabis retail launch for ... - Virginia’s House Bill 642 would create a framework for legal adult-use cannabis retail, stipulating ... Retail market for recreational weed passes Virginia ... - The legislation is expected to be signed by Gov. Abigail Spanberger. Virginia Lawmakers Approve Bill To Launch Cannabis Sales In 2027 - Lawmakers approved a compromise plan to regulate and tax adult-use cannabis, setting a 2027 start da... Virginia Governor Guts Retail Marijuana Sales Bills - NORML - Propose recriminalizing cannabis consumers and continuing to delay legal sales [PDF] 2026 General Assembly Session Reconvened Session Update Virginia Governor Proposes Sweeping Rewrite of ... - Virginia Governor Abigail Spanberger has proposed a full rewrite of legislation that would establish... Virginia Cannabis Cultivation License: 2026 Complete Guide - Virginia cannabis cultivation license guide: 5 tiers, 450 license cap, CCA application timeline, fee... Retail cannabis bill veto applies brakes to budding practice ... - Virginia Gov. Abigail Spanberger vetoed retail cannabis legislation, delaying the establishment of a... Virginia Governor Reports Progress On Marijuana Retail Sales Bill - Gov. Abigail Spanberger says talks with lawmakers have made significant progress toward a new bill t... State budget could provide end-run for Virginia's retail weed - "It would be really irresponsible if we didn't take this one final opportunity." Future of Cannabis in Virginia - Cannabis policy was once again a major topic of discussion for the 2026 General Assembly. Lawmakers ... VA Licensed Marketplace Awaits Governor's Signature - According to the legislation, the Cannabis Control Authority must begin approving licenses by Dec. 1... VA Legal Sales Bill Short Summary HB 642 / SB 542 - We Change Laws! 2026 Adult-Use Cannabis Business Opportunities in ... - Virginia’s HB 642 proposes a regulated adult-use cannabis market. Learn about license types, limits,... Virginia Adult-Use Cannabis Market: What Entrepreneurs & License Applicants Need to Know - Virginia’s adult-use cannabis market is closer to launching but major differences between the House ... Virginia Marijuana Bills Near Finish Line With Votes On Legalizing ... - Virginia lawmakers are nearing the finish line for a series of marijuana reform bills—including prop... Virginia Cannabis Facility Design: Expert Build & Optimization ... - Virginia's adult-use cannabis market opens July 2026 with up to 450 cultivation licenses and 60 proc... Charles Alovisetti's Post - LinkedIn - Virginia's cannabis bill just landed on the Governor's desk. Retail sales don't start until January ... Virginia's Cannabis Retail Roadmap: Key Proposed ... - In December 2025, Virginia’s Joint Commission released a draft of legislative changes to guide the s... Del. Paul Krizek announces Virginia retail marijuana compromise - Comments · What Happened When Black POWs Spoke Fluent German to Guards · Morning Joe 6/16/26 | 🅱️ Br... Virginia Cannabis Microbusiness License (2026 Guide) - Virginia cannabis microbusiness license rules are changing in 2026. Learn eligibility, canopy limits... Virginia's Impact Licensees: A Focused Guide for Social Equity ... - HB 642 requires issuance of 100 microbusiness licenses by October 1, 2026, and applications for such... Virginia's proposed cannabis law would give a licensing advantage ... - The bill to create a legal retail market for cannabis in Virginia would give some applicants an adva... Equity vs. Access: Explaining Virginia's New Cannabis Framework - Virginia’s cannabis legalization framework advances with major changes that include impact licenses,... US (VA): Legislation details micro business funding criteria for retail ... - Virginia's plan for a recreational cannabis market includes a way to help micro-businesses, formerly... In the closing hours of Virginia's legislative session, SB 542 was ... - In the closing hours of Virginia’s legislative session, SB 542 was revised to include: > A strict 2 ... Virginia Governor Urged to Preserve Access to Hemp Products - A bill on Virginia Governor Abigail Spanberger's desk threatens to severely limit access to popular ... Virginia Legalizes Recreational Marijuana Sales - LinkedIn - Virginia Lawmakers Reach Deal On Final Bill To Legalize Recreational Marijuana Sales （2） Here are th... Legalization and Regulatory Framework for Adult-Use Marijuana - The bill would establish a framework for the creation of a retail marijuana market in the Commonweal... Virginia House And Senate Lawmakers Advance Marijuana Sales ... - The march toward legalizing recreational marijuana sales in Virginia continues on, with the full Hou... Charles Alovisetti's Post - LinkedIn - 2026 Adult-Use Cannabis Business Opportunities in Virginia Under HB 642 Note: There are numerous can... 164th Virginia General Assembly - Wikipedia

Breaking: Minnesota SF 4401 Omnibus Cannabis Bill passed both chambers on May 17, 2026 — sending the most comprehensive cannabis policy update since legalization to Governor Walz. Read the full breakdown of what changes and timelines this bill would create, plus impacts across licensing, social equity, and regulation. Again, the bills HAVE TO be signed into law by our Governor in 2026, which is expected. The following is not Legal Advice. Make note that you should follow the guidance of your legal, complaince or advisory partners for the best time to make the changes, as most of these changes don't take place until August 2026. If you require assistance, contact us, and with the support of our network partners, we can guide you effectively. Quick Reference: Final 2026 Status on Minnesota Policy Changes Policy Area Final Status Technical/housekeeping (terminology, qualified applicant window) ✅ Passed in SF 4401 — awaiting Gov. signature SEA Ownership expansion up to 4 businesses at 33% investment (from 10%) ✅ Passed in SF 4401 Business structure change without a new license (LLC > Corporation, etc.) ✅ Passed in SF 4401 Hemp dual licensing (hold both cannabis + hemp license) ✅ Passed in SF 4401 Embedded battery (disposable vape) ban ✅ Passed in SF 4401 Local control / interim ordinance ban ✅ Passed in SF 4401 Medical + adult-use supply chain merger / macrobusiness option ✅ Passed in SF 4401 Medical endorsement canopy bonuses (+20% per tier) ✅ Passed in SF 4401 Metrc data classified as non-public ✅ Passed in SF 4401 Out-of-state LPHE testing through May 2027 ✅ Already signed law Microbusiness outdoor canopy ½ → 1 acre (SF 4876) ⚠️ Uncertain — not confirmed in final omnibus text. Which probably means NO. Federal 0.4 mg hemp THC container cap response ❌ No state fix passed; Nov. 12, 2026 deadline THC potency caps (15%/30% flower) ❌ Failed amendment — NOT in final law Let's Break it Down Technical / Housekeeping Changes ✅ Passed (in SF 4401) These cleanup changes to Chapter 342 are now law pending Walz's signature: Replaces "licensee" with "license holder" throughout the statute for consistency Repeals M.S. § 151.72 (the old temporary hemp registration law), since all hemp businesses now operate under Chapter 342 Removes NLRB violations as a license disqualifier; retains broader labor standards compliance Exempts good-faith, fair-market-value transactions between cannabis and hemp businesses from certain financial-relationship restrictions Hemp Regulatory and Labeling Updates ✅ Passed (in SF 4401) Important: The failed amendment (scs4401a21) that would have imposed mandatory 15%/30% THC potency caps and banned infused prerolls was NOT adopted — those limits are not in the final law. Dual licensing now allowed: The prohibition on one owner simultaneously holding both a cannabis business license and a hemp business license is removed. This is a major structural change for operators running both types of businesses. The dual licensing change (now passed in SF 4401) and LPHE transport authority under the medical endorsement give hemp operators a structural state-law pathway to pivot toward adult-use cannabis operations before November 12. SF 4401 creates two specific changes that, combined, give hemp operators a legal on-ramp into the adult-use cannabis system before that deadline: Dual Licensing Is Now Allowed. Previously, if you owned an LPHE business, you were blocked from simultaneously holding a cannabis business license (cultivator, retailer, manufacturer, etc.). SF 4401 removes that prohibition. This means a hemp beverage or edibles company can now apply for and hold an adult-use cannabis retailer or manufacturer license at the same time as their existing hemp license — without having to shut one down first. Medical Endorsement Unlocks Transport & Cross-Business Sales. Under the new medical endorsement rules in SF 4401, LPHE manufacturers that also obtain a medical endorsement can now transport products to other licensed cannabis/hemp businesses, with access to the adult-use + medical supply chain directly. This matters because the transport authority was one of the biggest operational gaps keeping hemp businesses siloed from the cannabis distribution network. QR codes may now be used on lower-potency hemp edible (LPHE) labels for source material disclosures, reducing label clutter Hemp-derived topical products must not exceed 0.3% THC A new extraction and concentration endorsement was created for LPHE manufacturers that extract/artificially derive cannabinoids. There are new regulations for LPHE broken down into three categories (more on that later). Cannabis Business Regulatory Updates ✅ Passed (in SF 4401) Business structure changes no longer require a new license — businesses converting entity types, transferring ownership, or restructuring no longer need to apply for a brand-new license. General license transfers — freely transferable with OCM approval. Non-social-equity licenses may be freely transferred, but only with prior written approval from OCM. Two exceptions block transfer: (1) the license holder has not yet received a final site inspection, or (2) the license holder is a social equity applicant. Social equity license ownership & transfers — restricted for 3 years. If your license was issued as a social equity license (under § 342.14, subd. 1b(b) or § 342.175(b)), it may only be transferred to another social equity applicant for the first three years after issuance. After year three, you may transfer to any entity. OCM's Division of Social Equity must review all social equity transfers and require prior written approval. One of the most impactful changes is to the True Party of Interest (TPII) rules, which previously capped how much equity an outside investor could hold in a social equity business. Under SF4401: An individual can now hold up to 33% ownership in up to four (4) separate social equity businesses simultaneously. This applies to both the application and licensing stages (Sections 26 and 27 of the bill). Previously, these overlapping ownership rules made it very difficult for social equity operators to attract outside capital without risking their SEA status. The 33% TPII carve-out is the headline change — it meaningfully opens the door to outside investment in SEA businesses. If you're structuring an entity for cultivation or retail, you can now bring in investors holding up to 33% without threatening the SEA status of your qualifying owners. Combined with the existing 65% controlling-ownership threshold, there's real flexibility to capitalize your operation before or after the lottery. The CanGrow and CanStartUp programs remain your best bet for non-dilutive grant and loan funding on the cultivation side. License preapproval — non-transferable. A license preapproval issued under § 342.125 cannot be transferred at all. This matters for applicants still in the preliminary approval stage. Establishes a 6-month expiration window for "qualified applicant" status — if you haven't converted to preliminary approval, OCM must deny your applications. What this is ultimately doing is pushing those folks who have licenses but didn't finalize them (aka sitting on them). When a new license IS required. This is the section most relevant to the 2026 SF 4401 change. Under the current statute, a brand-new license is required when: The legal business structure converts or changes (e.g., LLC → corporation), or The business dissolves, consolidates, reorganizes, undergoes bankruptcy/insolvency/receivership, merges, or assigns all/substantially all assets for the benefit of creditors. ⚠️ 2026 SF 4401 impact: The omnibus bill passed May 17 modifies this section. The new law allows certain business structure changes to be processed without requiring a completely new license application, subject to OCM review — effective August 1, 2026 for new license changes, and January 1, 2027 for reclassifications. This directly amends the scope of paragraph (d). Annual renewal. All licenses must be renewed annually. Tier adjustments. License holders may petition OCM to move up or down a tier within a license category (e.g., from a smaller cultivator tier to a larger one) if they meet all applicable requirements. This is the mechanism for growing your canopy size within the same license category without applying for an entirely new license. Relocation authority. OCM may by rule permit a licensed cannabis business or approved operational location (cultivation site, manufacturing, retail) to relocate, adopt application standards for relocation, and charge a fee not to exceed $250 for reviewing and processing relocation applications. A relocation does not extend or modify the existing license term. Embedded (non-removable) battery ban: Manufacturing and selling cannabinoid products with non-removable batteries (e.g., disposable vapes) is prohibited, with a transition period included Endorsement framework reorganized: All cannabis businesses must now obtain specific endorsements (cultivation, retail, extraction, transport, etc.) before conducting those activities All cannabis flower sold to customers or patients must be pre-packaged OCM enforcement strengthened: OCM may now prohibit unlicensed sellers and deny licensure to applicants with previous revocations Seed-to-sale (Metrc) data is now classified as non-public — protects your business's inventory, sales, and tracking records from public records requests Local Government / Control Changes ✅ Passed (in SF 4401) Interim ordinance authority removed: Local governments can no longer issue interim ordinances on the time, place, and manner of cannabis business operations Statewide minimum access standard: Localities may not cap cannabis retailers below 1 per 12,500 residents OCM may now deny final license authorization if an applicant's location violates local zoning, State Fire Code, or Building Code Local governments must share their age-verification compliance check results with OCM Businesses must register with their city/county before making retail sales Medical + Adult-Use Supply Chain Streamlining ✅ Passed (in SF 4401, Article 3) This was the most controversial piece — it made it through as part of the omnibus. New Macrobusiness license created, replacing the medical cannabis combination license. The macrobusiness is the only license type required to serve the medical market. Canopy bonuses for medical endorsements (voluntary for all license types except macrobusiness): License Type Current Indoor Canopy Medical Endorsement Bonus New Total Microbusiness 5,000 sq ft +1,000 sq ft (+20%) 6,000 sq ft Mezzobusiness 15,000 sq ft +3,000 sq ft (+20%) 18,000 sq ft Cultivator 30,000 sq ft +6,000 sq ft (+20%) 36,000 sq ft Macrobusiness (new) 45,000 sq ft Required to serve medical Up to 8 retail locations Businesses receiving the canopy bonus must sell 25% of their additional harvest to other businesses with medical endorsements. Separate Metrc instances for medical vs. adult-use eliminated (effective 2027) All retail businesses with a medical retail endorsement may now deliver to registered patients and caregivers Microbusinesses and mezzobusinesses with a medical endorsement may now transport products to other cannabis businesses Microbusiness Outdoor Canopy Increase (SF 4876 / HF 4570) ⚠️ Status Unclear SF 4876 was introduced March 26, 2026 and referred to the Senate Commerce; HF 4570 was slated for House Ways and Means. This was the standalone bill — not part of the omnibus — that would double microbusiness outdoor grow limits from ½ acre to 1 full acre. Bottom line: SF 4876 / HF 4570 did NOT pass. Both bills stalled in committee and were not folded into the SF 4401 omnibus that passed May 17. As of the May 5 research date it was not included in SF 4401's first engrossment It is not yet confirmed whether it was picked up as an amendment during the final floor action on May 17. Outdoor microbusiness cultivators should watch for the enrolled bill text or contact OCM to confirm whether the 1-acre floor made it into the final signed version. OCM could still adjust the limit up or down each licensing period based on market demand, but could not set the floor below 1 acre (up from the current ½-acre floor). Out-of-State Hemp Testing ✅ Already Signed Law Already enacted in March 2026 — Governor Walz signed HF 3615, allowing LPHE manufacturers to continue using qualified out-of-state testing labs through May 31, 2027 while Minnesota builds in-state capacity. Federal Hemp THC Cap (0.4 mg/container) 🚨 Unresolved, Clock Ticking No Minnesota state fix has passed for this yet.The dual licensing change (now passed in SF 4401) and LPHE transport authority under the medical endorsement give hemp operators a structural state-law pathway to pivot toward adult-use cannabis operations before November 12. Right now, many businesses selling hemp-derived THC products (gummies, beverages, vapes) operate exclusively under LPHE licenses — not adult-use cannabis licenses. When the federal 0.4 mg/container cap hits on November 12, 2026, those products become legally precarious under federal law regardless of what Minnesota says. Federal P.L. 119-37 (signed Nov. 12, 2025) narrows the definition of "hemp" and caps finished hemp-derived THC products at 0.4 mg total THC per container, effective November 12, 2026 This would effectively ban nearly all current LPHE gummies, beverages, and vapes under federal law Minnesota's estimated $180–210 million LPHE market (1,658+ licensed retailers) faces existential risk OCM has stated it will continue implementing Chapter 342 under state law regardless, but federal preemption litigation is an open legal question Federal 280E Tax Relief ✅ Already In Effect for Medical DEA, Washington meets again on June 29th to discuss further rescheduling efforts Not a state legislative action, but critically important: On April 22, 2026, the DOJ officially reclassified medical marijuana from Schedule I to Schedule III of the Controlled Substances Act, per President Trump's executive order This eliminates the IRS Section 280E tax penalty, allowing Minnesota cannabis businesses to deduct standard operating expenses (rent, payroll, COGS) from federal taxable income for the first time Effective immediately — no state legislative action required Need any help with the above adjustments or changes, please feel free to reach out

With more retailers and now outdoor cultivating planting for the upcoming grow season, May 11–15 is an event-heavy industry week in the Minneapolis Cannabis Industry, centered on capital, compliance, licensing, and market development, making it one of the strongest cannabis networking windows of the spring. May Cannabis Week at a Glance May 12–13: Flourish Investment Forum at the Minneapolis Event Centers, focused on founders, operators, investors, and industry experts, with programming around funding, compliance, and building durable cannabis businesses. The Flourish Investment Forum is two days of programming built around what moves the cannabis industry forward: funding, compliance, and building businesses that last. Hear from dynamic speakers, dig into high-caliber panels, and sit across the table from the founders, operators, and investors shaping what this industry looks like next. The agenda will sharpen your strategy. The room will change your trajectory. The event also includes curated networking and a private dinner on May 13. Get tickets for the Flourish Investment Forum. Prices for general admission, 1-day pass $139, both days $199. May 13 (Evening): Flourish Investment Forum's Networking Cocktail Hour and Dinner at The Glass House (Cost $99), downtown Minneapolis. Get tickets at: https://events.humanitix.com/flourish-investment-forum-ywrqzcyz/tickets May 14–15: NECANN Minnesota Cannabis Convention Located at the Minneapolis Convention Center, NECANN’s first Minnesota convention was built as a business-focused expo with education, networking, exhibitors, and speakers. Times are Thursday hours as 10 a.m.–4 p.m. and Friday hours as 10 a.m.–3 p.CST. See educational session lineup here. Ticket Options through NECANN. NECANN Licensee/Buyer Pass Application. Limited number of 2-day, FREE passes. To be eligible for consideration, applicants must be an owner and/or a qualified buyer (of cannabis products and/or ancillary services) at a licensed cannabis company. You'll need to upload a copy of your company's license, and your LinkedIn profile or other proof of position at the end of the application. Request your FREE 2 Day pass through the NECANN organization. 2-Day All Access General Admission. This ticket is good for both convention days with expo floor and programming access at a steal of a price of only $35. Click here to purchase your Tickets. May 14 (Evening): The Official NECANN After-Party at the Hook & Ladder Theater

Prepared for: Minnesota Cannabis Operators & Stakeholders Research Date: May 5, 2026 (We will update once legislative commences end of May. Primary Sources: MN Office of Cannabis Management, 94th Legislature (2025–2026) Minnesota's Office of Cannabis Management (OCM) entered the 2026 legislative session with a comprehensive reform agenda—six discrete policy proposals submitted as individual bills plus a landmark recommendation to merge the bifurcated adult-use and medical cannabis supply chains. These proposals are consolidated into the Omnibus Cannabis Bill (SF 4401/HF 4203), sponsored by Sen. David Dibble and Rep. Jessica Hanson, which cleared the Senate Commerce and Consumer Protection Committee on April 7, 2026, and is advancing through the Senate Finance Committee as of May 2026. The 2026 session opened February 17 and is expected to conclude in May. Layered on top of OCM's agenda are critical federal developments—chiefly the November 12, 2026 effective date for a new federal definition of hemp that would cap finished hemp-derived THC products at 0.4 milligrams per container, threatening Minnesota's estimated $180–210 million Lower-Potency Hemp Edible (LPHE) market. An additional standalone bill, SF 4876/HF 4570, seeks to double the outdoor canopy limit for microbusinesses from one-half acre to one acre and remains in committee as of late March 2026. Section 1: Legislative Context and Background 1.1 The Regulatory Landscape Entering 2026 With the full launch of Minnesota's adult-use cannabis market in 2025, all three market segments—adult-use cannabis, medical cannabis, and hemp-derived cannabinoids—now operate under a single regulatory and licensing framework governed by Minnesota Statutes, Chapter 342. By year-end 2025, OCM had issued 118 full cannabis licenses across all business types and granted approximately 1,405 preliminary approvals, indicating a robust pipeline of operators expected to come online through 2026. OCM has also noted that the state's total cannabis canopy currently stands at fewer than 400,000 square feet—less than 20% of the estimated 2 million square feet the market could sustain. In developing its 2026 recommendations, OCM engaged with partner agencies, legislators, federal partners, Tribal Nations, patients, consumers, and industry stakeholders. The six proposals target technical consistency, data practices, hemp labeling, cannabis business regulation, local government roles, and legislative reporting efficiency, while the seventh—the supply chain streamlining proposal—addresses the structural division between the medical and adult-use markets. 1.2 Key Legislative Timeline Milestone Date OCM Supply Chain Streamlining Report submitted to Legislature January 15, 2026 2026 Legislative Session opens February 17, 2026 SF 4876 (microbusiness 1-acre canopy) introduced March 26, 2026 OCM 2026 Legislative Policy Proposals document published March 2026 Senate Commerce & Consumer Protection Committee approves SF 4401 April 7, 2026 SF 4401 (1st Engrossment) published May 4, 2026 Federal hemp THC enforcement effective date November 12, 2026 Supply chain changes (if enacted) anticipated effective date 2027 Section 2: The Six OCM Policy Proposals Proposal 1 — SF 4403 / HF 4199: Technical and Housekeeping Updates This bill brings consistency and clarity to the terminology and operational mechanics of Chapter 342, correcting gaps identified during the first years of implementation. Key provisions: Repeals M.S. § 151.72, the temporary hemp business registration statute, since all hemp businesses are now licensed under Chapter 342. Replaces "licensee" with "license holder" throughout statute for consistency. Establishes a six-month expiration window for "qualified applicant" status; OCM must deny applications from lapsed applicants (M.S. § 342.14). Clarifies that "Department of Labor" references mean the state agency, not the federal entity, and removes National Labor Relations Board violations as a cannabis license disqualifier while retaining other labor standards compliance requirements (M.S. § 342.16). Removes an ingestible hemp-derived consumer product category that was never approved and directs applicants to the established petition process (M.S. § 342.27). Clarifies that cannabis testing facilities and cannabis event organizers can "perform other actions approved by the office," aligning them with all other license types (M.S. §§ 342.37, 342.39). Exempts good-faith, fair-market-value transactions between cannabis and hemp businesses from certain financial relationship restrictions (M.S. § 342.23). Business Impact: Procedural and clarifying. The six-month "qualified applicant" expiration is the most actionable change—businesses with pending preliminary approval status must convert to "preliminary approval" within six months or face application denial. Monitor your application status closely. Proposal 2 — SF 4402 / HF 4200: Data Practice Updates and Clarifications This proposal restructures OCM's data request process to improve public access to appropriate information while protecting confidential business data. Key provisions: Clarifies which applicant and license holder data are public vs. non-public (M.S. § 342.20). Declares that all data reported through the Metrc/statewide monitoring system (seed-to-sale tracking) is considered non-public data. Makes an applicant's application status public, but preserves social equity applicant status as non-public. Business Impact: Operators benefit from the explicit protection of Metrc data as non-public. This eliminates ambiguity about competitors or the public accessing your inventory, sales, or seed-to-sale records through public records requests. Useful for competitive intelligence protection. Proposal 3 — SF 4429 / HF 4201: Product Labeling and Hemp Business Regulatory Updates This proposal makes targeted reforms to hemp business licensing and labeling requirements, with one transformative change for operators holding both cannabis and hemp licenses. Key provisions: Removes the prohibition on one owner simultaneously holding both a cannabis business license and a hemp business license (M.S. §§ 342.43, 342.44). This is a significant structural change reflecting the market's evolution. Allows hemp businesses to use a QR code to disclose source material information on lower-potency hemp edible labels, reducing label clutter while maintaining consumer transparency (M.S. § 342.63). Updates general labeling requirements for cannabis and hemp products to better reflect each product type. Defines labeling requirements for products using imported materials, aligning them with in-state products. Establishes that hemp-derived topical products must not exceed 0.3% THC (M.S. § 342.66). Removes the requirement for THC-free products to include the universal THC symbol; other label requirements (age prohibitions, etc.) still apply. Business Impact: The dual-licensing permission is the most strategically significant provision here. Previously, cannabis license holders who also operated hemp businesses faced a legal conflict. With this change, operators can legally hold both license types, enabling seamless integration of hemp-derived product lines into cannabis retail operations. For microbusinesses and mezzobusinesses, this opens the door to carrying a broader product portfolio without structural restructuring. Proposal 4 — SF 4540 / HF 4398: Cannabis Business Regulatory Updates This proposal is the most substantive of the six regulatory proposals, touching licensing flexibility, enforcement authority, environmental policy, and the operational framework for endorsements. Key provisions: Removes the requirement to acquire a new license when a business changes structure (e.g., converting from an LLC to a corporation, or facilitating a license transfer), allowing flexibility in business evolution (M.S. § 342.12). Strengthens OCM enforcement authority: OCM may now prohibit and take action against unlicensed sellers and deny licensure to applicants with previous license revocations (M.S. § 342.09). Bans manufacture and sale of cannabinoid products with embedded (non-removable) batteries, citing environmental disposal risks and worker safety. A transition period is included (M.S. § 342.26). This provision originated from a proposal by the Minnesota Pollution Control Agency (MPCA). Reorganizes the endorsement and authorized activities structure across all cannabis business license types for greater consistency. Critically, no substantive changes are made to authorized activities, and no canopy or manufacturing limits are changed in this proposal. Requires cannabis businesses to obtain specific endorsements before cultivating, manufacturing, or retailing (cultivation endorsement, retail operations endorsement, etc.). All cannabis flower sold to customers or patients must be pre-packaged. Establishes a new endorsement framework: OCM must deny an endorsement application if the license holder has had an endorsement canceled within the past five years, owes outstanding fines, or does not meet requirements. Business Impact: The business structure flexibility provision is very operator-friendly—it eliminates a major administrative and financial burden for businesses undergoing investment recapitalization, ownership transfers, or corporate restructuring. The embedded battery ban affects vape product lines significantly; disposable vapes are among the top sellers at dispensaries, and operators will need to transition to products with removable batteries during the transition period. The MPCA has been the driving force behind this provision. Proposal 5 — SF 4519 / HF 4202: Local Control Clarifications This proposal clarifies the relationship between OCM and local governments in the cannabis licensing process, addressing persistent ambiguity around zoning, registration caps, and compliance checks. Key provisions: Removes expired temporary local prohibition authority, as the time window for such prohibitions has passed (M.S. § 342.13). Clarifies that OCM may deny final license authorization if an applicant's location would violate local zoning ordinances, State Fire Code, or State Building Code (M.S. § 342.14). Refines the county registration cap framework: a county with delegated registration authority may now set a cap that accounts for city and township populations, preventing a delegating city from hosting retail locations beyond its own population-based limit (M.S. § 342.13). Establishes a statewide minimum access standard: local jurisdictions may not set a cap of fewer than one retailer per 12,500 residents, while still permitting more if they choose. Requires local governments to share age-verification compliance check data with OCM (M.S. § 342.22). Requires cannabis businesses to register with their city, town, or county before making retail sales. Business Impact: The clarification of zoning, fire code, and building code as grounds for OCM to deny licensure could create new friction points if local governments use these provisions as de facto veto tools. Businesses in the application pipeline should conduct thorough pre-authorization site assessments. The 1-per-12,500 minimum access floor is positive for markets where local caps have been unreasonably restrictive. Proposal 6 — SF 4401 / HF 4203: Increased Efficiency in Legislative Reporting This administrative proposal adjusts OCM's annual reporting requirements to eliminate duplicative obligations and improve data quality. Key provisions: Removes items from OCM's required annual report that fall outside OCM's jurisdiction, replacing them with a requirement for OCM to collaborate with other state agencies and local partners that collect the relevant data. Combines duplicative items and reports into a more streamlined structure. Business Impact: Minimal direct impact on operators. This improves the quality of the market data OCM publishes for industry stakeholders by ensuring data comes from authoritative agency sources rather than OCM extrapolations. Section 3: Supply Chain Streamlining Proposal — SF 4541 / HF 4397 3.1 Background and Legislative Mandate In the 2025 session, the Legislature mandated OCM to develop a proposal to merge the bifurcated adult-use and medical cannabis supply chains. Per state law (Session Laws 2025, Chapter 31, Section 107), the proposal must allow for co-location of cultivation and manufacturing, permit shared equipment, and preserve access to medical cannabis for patients with rare and childhood diseases. OCM submitted its proposal to the Legislature on January 15, 2026, following a six-month engagement process involving patients, businesses, advocates, Tribal partners, and agency staff. The proposal is organized around three guiding principles: (1) aligning with OCM's equity and public health mission; (2) protecting continuity for the 69,000+ Minnesotans enrolled in the medical registry; and (3) incorporating feedback from partners and data from the medical program. If enacted, most changes would take effect in 2027 to allow adequate transition time for OCM, businesses, and the statewide tracking system. 3.2 The Four Provisions of the Proposal Provision 1: Safeguarding Medical Cannabis Supply and Patient Protections Businesses with a medical cannabis retail endorsement would serve medical patients alongside adult-use customers without maintaining separate inventories. Requirements for endorsed businesses would include: Employing a licensed pharmacist or medical cannabis consultant for patient consultation. Establishing priority service for patients (dedicated lines, curbside pickup, advance ordering, etc.). Carrying all products identified by OCM as having high medical need. Patients would also gain access to specific medical cannabis products not subject to adult-use potency limits, and hemp-derived cannabinoids would be permitted in medical products. Provision 2: Encouraging Business Participation in the Medical Market The proposal removes the current requirement for separate medical and adult-use cannabis cultivation and manufacturing activities and inventories. For license holders who voluntarily obtain a medical endorsement: License Type Current Canopy Medical Endorsement Bonus New Total Microbusiness (indoor) 5,000 sq ft +1,000 sq ft (+20%) 6,000 sq ft Mezzobusiness (indoor) 15,000 sq ft +3,000 sq ft (+20%) 18,000 sq ft Cultivator (indoor) 30,000 sq ft +6,000 sq ft (+20%) 36,000 sq ft Businesses receiving the canopy bonus would be required to sell one-quarter of their additional harvest to other businesses with medical endorsements. Similarly, microbusinesses and mezzobusinesses with a medical manufacturer endorsement producing high-need products could manufacture 25% more than current manufacturing limits. Businesses with a medical retail endorsement could qualify for additional retail locations if all stores sell medical cannabis and some are located in areas OCM designates as high-need. Provision 3: Ensuring Fairness Between License Types The proposal equalizes authorized activities across all license types holding a medical endorsement: All retail businesses with a medical retail endorsement may deliver products to registered patients and designated caregivers—an activity previously exclusive to certain license types. Microbusinesses and mezzobusinesses with a medical endorsement may transport products to other cannabis businesses, currently only allowed for cannabis transporters and the medical combination business. This transportation authority extends to selling and transporting LPHE products to LPHE retailers and wholesalers. Provision 4: Creating the New Macrobusiness License Type To replace the current medical cannabis combination business license and align with the existing size-tiered framework, the proposal establishes a macrobusiness license: License Type Indoor Canopy Retail Locations Microbusiness 5,000 sq ft 1 Mezzobusiness 15,000 sq ft varies Cultivator 30,000 sq ft n/a Macrobusiness (proposed) 45,000 sq ft Up to 8 The macrobusiness would be the only license type required to serve the medical market, including obligations to: obtain at least two medical endorsements (including the medical manufacturer endorsement), and maintain retail locations in high-medical-need areas. Additionally, OCM would establish a petition process for microbusinesses and mezzobusinesses to request reclassification as a mezzobusiness or macrobusiness, with priority given to businesses with medical endorsements and equal allocation between social equity and non-social equity businesses. 3.3 Stakeholder Feedback Summary OCM's six-month engagement process surfaced both strong support and areas of concern: Supported elements: Removal of the requirement for separate Metrc instances and inventory chains for medical vs. adult-use. License reclassification pathway with equal access for social equity businesses. Addition of delivery and transportation activities for businesses with a medical endorsement. Areas of concern: Market oversaturation: Several partners flagged the proposed canopy increases and additional retail locations as potential drivers of oversupply in a still-maturing market. Canopy size alignment: Stakeholders debate whether the macrobusiness at 45,000 sq ft is too low (compared to the current medical combination business's 60,000 sq ft limit) or too high relative to other license types. Access to capital: Multiple partners urged that the proposal include grant or loan programs to help social equity and small businesses compete with larger operators, though OCM noted this proposal is policy—not fiscal—in nature. Priority service enforcement: Both patients and businesses acknowledged that further work is needed to define and enforce patient-priority service requirements. 3.4 Legislative Bill Status SF 4541/HF 4397 is incorporated as Article 3 of the Cannabis Omnibus Bill (SF 4401, 1st Engrossment), which has passed out of the Senate Commerce and Consumer Protection Committee and is before the Senate Finance Committee as of May 4, 2026. Section 4: Microbusiness Outdoor Canopy — The 1-Acre Question 4.1 Current Law and Proposed Change Under current Minnesota law (M.S. § 342.28, Subd. 2), a cannabis microbusiness cultivating outdoors may grow up to one-half acre of mature, flowering plants. Indoor cultivation remains capped at 5,000 square feet of plant canopy.SF 4876, introduced by Sen. Lindsey Port (DFL) on March 26, 2026, and its House companion HF 4570 (introduced by Rep. Nolan West) would amend § 342.28 to double the outdoor cultivation limit to one full acre. The indoor limit would not change. OCM would retain authority to adjust the outdoor limit upward or downward based on market demand, but could not set the floor below one acre for newly issued licenses if the bill becomes law. 4.2 Legislative Status SF 4876 received its first reading on March 26, 2026, and was referred to the Senate Commerce and Consumer Protection Committee. The House companion, HF 4570, has been noted for addition in Ways and Means as part of a broader cannabis package. Critically: SF 4876/HF 4570 is NOT included in OCM's six main agency proposals and is NOT part of the Cannabis Omnibus Bill (SF 4401) in its current 1st Engrossment form. It appears to be moving as a separate legislative vehicle. The OCM's supply chain streamlining proposal (SF 4541/Article 3 of the Omnibus Bill) does include a related, but distinct, 20% canopy bonus for microbusinesses that voluntarily obtain a medical cannabis cultivation endorsement. 4.3 Strategic Significance For outdoor microbusiness cultivators, the difference between 0.5 acres and 1.0 acre of mature, flowering plants represents a potential doubling of flower production capacity. Given that Minnesota's total licensed cannabis canopy (roughly 400,000 sq ft) sits below 20% of estimated market capacity, the case for expansion is strong from a supply perspective. However, OCM's own supply chain report noted stakeholder concerns about market oversaturation, particularly from cumulative canopy increases across multiple license types. Section 5: 2025 Chapter 342 Changes — Cross-Reference The 2026 proposals build directly on the foundation laid by Laws of Minnesota 2025, Chapter 31 (SF 2370), signed by Gov. Walz and effective upon enactment. The major 2025 changes are summarized below for cross-reference: 5.1 Licensing and Market Launch Testing facility variance process: OCM may now license testing facilities with pending (not yet final) accreditation, addressing the risk of a testing bottleneck at market launch. Local registration timing: Local governments may issue a retail registration to an applicant with preliminary approval status rather than waiting for full licensure. Simplified application process: Duplicative requirements and the two-officer signature requirement were removed. Social equity criteria expansion: Expanded to include applicants with stays of adjudication or juvenile delinquency adjudications (Minn. Stat. ch. 260B). 5.2 Authorized Activities and Operations Event samples permitted: The prohibition on samples at licensed cannabis events was repealed; retailers may offer samples on-site at events for adults 21+. Transportation simplified: Removed the requirement for two employees per transport vehicle and randomized routing. Expanded business-to-business activities: Microbusinesses and mezzobusinesses may now purchase cannabis products, LPHE, and hemp-derived consumer products from other licensed businesses. Cultivators may sell immature plants, seedlings, and flower to other cannabis businesses. Municipal cannabis stores: Cities/counties that own a cannabis retailer may now also hold an LPHE retailer license. 5.3 LPHE Industry Changes New LPHE Wholesaler License: A third hemp business license type was created (joining manufacturer and retailer), with authority to import (via endorsement), transport, and buy/sell LPHE products between licensed businesses. Application fee: $250; license/renewal fee: $10,000. LPHE beverage serving size: Single-container beverages may now contain up to 10 mg THC per container and be labeled as one serving (previously required to be labeled as two 5 mg servings). CBD/CBG/CBN/CBC limits increased: From 25 mg to 100 mg per serving in LPHE products. LPHE delivery endorsement: New endorsement for LPHE retailers to deliver directly or through a licensed delivery partner. LPHE event off-site consumption: Retailers with an on-site consumption endorsement may sell LPHE beverages at off-site events (up to 4 days, requires local authorization and event holder's on-sale license). LPHE export manufacturing: Licensed manufacturers may produce non-Minnesota-compliant products for export to other states, with strict segregation and labeling requirements. 5.4 Medical Cannabis Program Civil and criminal patient protections: Anti-discrimination protections in housing, employment, and education were strengthened; injunctive relief access added; tribal medical patients included. Remote consultation authority: Ensures remote access for patients seeking consultation, particularly in rural areas. Tribal medical patient reciprocity: Tribal patients with documentation may access medical products at licensed businesses. Visiting patient reciprocity: Out-of-state medical patients with documentation may access medical products in Minnesota. 5.5 Cannabis Tax Changes The cannabis gross receipts tax was increased from 10% to 15%, effective for sales after June 30, 2025. All revenues are now deposited into the general fund, eliminating the separate local cannabis aid account, effective January 2, 2026. 5.6 Supply Chain Mandate 2025's Chapter 31 included the legislative directive for OCM to develop the supply chain streamlining proposal—the very report OCM delivered January 15, 2026, which now forms Article 3 of the 2026 Omnibus Bill. Section 6: Federal Hemp THC Limits — November 12, 2026 Deadline 6.1 What Congress Changed On November 12, 2025, President Trump signed the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (P.L. 119-37). Section 781 of that Act materially amended the definition of "hemp" under 7 U.S.C. § 1639o. Because the Controlled Substances Act excludes "hemp" by cross-reference to the Agricultural Marketing Act, narrowing the hemp definition pushes many hemp-derived cannabinoid products back into Schedule I status under the CSA once the changes take effect. Enforcement is delayed 365 days from enactment—making the effective date November 12, 2026. 6.2 The Three Key Changes Change Old Standard New Standard THC threshold type Delta-9 THC only, 0.3% dry weight Total THC (delta-9 + THCA + delta-8), 0.3% dry weight Per-container finished product limit No per-container limit 0.4 milligrams total THC per container Synthetic cannabinoids Legal if derived from hemp Expressly prohibited (delta-8 via CBD isomerization, HHC, etc.) 6.3 Impact on Minnesota's LPHE Market The per-container limit of 0.4 mg is the most devastating provision for the existing market. A typical delta-8 gummy contains 25 mg per piece; a standard hemp-derived vape cartridge contains 50 mg or more. Minnesota's LPHE products sold under Chapter 342 generally contain 5 mg THC per serving, with up to 50 mg per package. The new federal 0.4 mg per container cap would make essentially every commercially available hemp THC product federally illegal. Minnesota-specific exposure: More than 1,500 licensed LPHE businesses (gas stations, convenience stores, hemp shops, brew pubs) are currently operating. An estimated 1,658 LPHE retailer licenses have been issued. Minnesota's hemp-derived THC market was valued at approximately $180–210 million in 2025. 6.4 Minnesota's State Response OCM has indicated it will continue to implement Chapter 342 under current state law regardless of the federal enforcement date, as state law does not automatically defer to the federal standard. Key state-level responses in 2026 include: Gov. Walz signed a bipartisan bill extending out-of-state testing for LPHE products through May 2027, preserving limited in-state testing capacity for the adult-use industry. OCM reopened LPHE license applications in April 2026 after processing more than 2,200 prior applications. Target Corporation obtained 72 LPHE licenses in April 2026, establishing the retailer as Minnesota's largest LPHE license holder. The 2026 Legislature is considering whether to address federal preemption directly through state-level product protections—an unresolved legal gray area. OCM's 2026 legislative proposal (SF 4429) to allow the same owner to hold both cannabis and hemp licenses, combined with the supply chain streamlining proposal allowing LPHE transport under a medical endorsement, provides LPHE operators a structural pathway to shift operations toward the OCM-licensed adult-use market if the federal ban eliminates the standalone hemp retail business model. Section 7: Other Significant 2026 Legislative Developments 7.1 Cannabis Omnibus Bill — Additional Provisions Beyond the six OCM proposals and the supply chain bill, the Omnibus Cannabis Bill (SF 4401, 1st Engrossment) includes additional legislative provisions worth tracking: License denial for post-legalization illegal sales: Individuals convicted of illegally selling marijuana after August 1, 2023, are barred from holding a cannabis license unless five years have passed. Social equity license classification: OCM must formally classify and identify which licenses are designated for social equity applicants. State law protection: Licensed cannabis and hemp activities in compliance with state law are declared lawful and protected from seizure or prosecution. 7.2 True Party in Interest (TPII) Rules Rep. Nolan West (R) has proposed increasing the allowed percentage of overlapping ownership between adult-use licensees under TPII rules from the current 10% to 35%. As of March 2026, a legislative compromise was being discussed at approximately 20%. This would significantly affect investment structures for multi-license operators and investors seeking cross-entity ownership. 7.3 Possession Threshold Concerns A provision in OCM's bill would define possession of two times the legal possession limit as presumptive "intent to sell," with fines that could disqualify the individual from holding a cannabis license. Industry advocates, including SotaCANN have raised concerns about this provision's scope and fairness. 7.4 Cannabis Reclassification — Federal 280E Relief On April 22, 2026, the Department of Justice officially reclassified medical marijuana from Schedule I to Schedule III of the Controlled Substances Act, triggered by President Trump's 2025 executive order. This removes the IRS Section 280E tax penalty, which had previously prevented cannabis businesses from deducting standard operating expenses (rent, payroll, COGS) from their federal taxable income. For Minnesota's plant-touching businesses, this is a transformative economic improvement that takes effect immediately and does not require state legislative action. Section 8: Impact Analysis by Business Type 8.1 Cannabis Microbusinesses Issue Current State 2026 Change/Status Business structure change New license required No new license required if SF 4540 passes Outdoor canopy 0.5 acres Bill introduced (SF 4876) to increase to 1 acre; in committee Medical endorsement canopy bonus N/A +20% (to 6,000 sq ft indoor) if supply chain bill passes Dual cannabis+hemp licensing Prohibited Allowed under SF 4429 LPHE transport (with medical endorsement) Prohibited Authorized under SF 4541 Delivery to medical patients (with endorsement) Restricted Authorized under SF 4541 Federal 280E Applies Eliminated as of April 22, 2026 Metrc separation (medical vs. adult-use) Required Eliminated under SF 4541 (if passed, 2027) 8.2 Cannabis Mezzobusinesses Same dual licensing, business structure, and 280E benefits as microbusinesses. Medical endorsement canopy bonus: +3,000 sq ft (to 18,000 sq ft indoor). Potential reclassification pathway to macrobusiness under supply chain bill. Manufacturing bonus: +25% above current limits with medical manufacturer endorsement. 8.3 LPHE Retailers and Manufacturers Existential federal threat: November 12, 2026 federal ban threatens the viability of all hemp THC products above 0.4 mg per container. Out-of-state testing: Extended through May 2027. Dual licensing: Can now hold both LPHE and cannabis licenses under the same ownership. Strategic pivot: The LPHE transport activity authorized under the supply chain bill, combined with dual licensing, enables LPHE operators to transition toward OCM-licensed adult-use operations before the federal ban takes effect. 8.4 Medical Cannabis Combination Businesses (Existing) Under the supply chain streamlining proposal, these businesses would be reclassified as macrobusinesses. The macrobusiness would be required (not optional) to maintain medical market obligations and would be subject to new canopy alignment under the 45,000 sq ft unified model. Controversy exists among current holders about whether 45,000 sq ft represents a reduction or improvement from their current split-canopy structure. 8.5 Cultivators and Manufacturers Cultivators may benefit from a +20% canopy increase with medical cultivation endorsement (to 36,000 sq ft indoor), with mandatory sale of 25% of additional harvest to businesses with medical endorsements. Embedded battery ban affects manufacturers of disposable vape products (transition period included). Cultivators now required to obtain a cannabis cultivation endorsement under SF 4540. All cannabis flower sold to customers or patients must be pre-packaged. Section 9: Key Timelines and Action Items for Stakeholders 9.1 Immediate Actions (Before July 2026) Check qualified applicant status: The six-month expiration for "qualified applicant" status (SF 4403) means any business with pending preliminary approval must convert to "preliminary approval" status within six months or face denial. Act immediately if your application is in qualified applicant status. Review vape product lines: Begin transitioning vape and cannabinoid product manufacturing away from embedded battery designs. The embedded battery ban (SF 4540) includes a transition period, but product development cycles require early action. Evaluate dual licensing opportunity: If you operate both cannabis and hemp businesses, engage legal counsel to restructure ownership to take advantage of the new dual-license permission under SF 4429 once enacted. Plan for 280E deduction benefits: Work with a CPA familiar with cannabis tax law to capitalize on the Section 280E elimination effective April 22, 2026, including retroactive implications. 9.2 Mid-Term Actions (July–November 2026) Federal hemp ban contingency: LPHE businesses must develop a contingency plan for November 12, 2026. Options include: transitioning to an OCM-licensed adult-use dispensary model (requires cannabis licensure), divesting hemp THC product lines, lobbying for federal legislative intervention, or exploring state preemption litigation. Medical endorsement strategy: Evaluate whether obtaining a medical cannabis endorsement makes operational sense given the 20% canopy bonus (if the supply chain bill passes) and access to delivery and transport activities—weighed against obligations such as priority patient service, mandatory high-need product carrying, and harvest sale requirements. Track SF 4876 (1-acre outdoor canopy): Monitor the bill's progress in the Senate Commerce and Consumer Protection Committee and whether it is picked up as an amendment to the House Ways and Means cannabis package. Outdoor microbusiness cultivators should plan both with and without this provision. 9.3 Long-Term Positioning (2027 and Beyond) Macrobusiness reclassification: If the supply chain streamlining bill (SF 4541) passes, plan for the 2027 implementation timeline. OCM will need to build the endorsement infrastructure and update Metrc; businesses holding current medical cannabis combination licenses should engage early with OCM's implementation process. Metrc unified instance: The removal of separate Metrc instances for medical and adult-use operations (if supply chain bill passes) will require operational changes to inventory management protocols. Begin planning with your compliance team now for a 2027 transition. License reclassification petition: Under the supply chain proposal, OCM will establish a petition process for microbusinesses and mezzobusinesses to reclassify. Priority will be given to businesses with medical endorsements and equitably split between social equity and non-social equity operators. Begin evaluating whether reclassification aligns with your growth strategy. Section 10: Partner Agency and Legislator Notes Minnesota Pollution Control Agency (MPCA) The MPCA is the originating partner agency behind the embedded battery ban provision in SF 4540. The agency's concern centers on disposable vapes leaching chemicals into landfills and creating worker hazard during disposal. Industry groups including SotaCANN oppose the ban on the grounds that black-market sellers will continue selling disposable vapes while licensed businesses lose competitive products. The MPCA's environmental mandate gives this provision strong administrative support, making passage likely. Key Legislative Authors Legislator Role Sen. David Dibble (DFL) Lead author, SF 4401 Omnibus Cannabis Bill; SF 4540, SF 4403, SF 4402, SF 4519, SF 4401, SF 4541 Sen. Lindsey Port (DFL) Co-author, SF 4401; author, SF 4876 (1-acre outdoor canopy); SF 4429 Sen. Matt Klein (DFL) Co-author, SF 4429 Rep. Jessica Hanson (DFL) Lead House author, HF 4199–HF 4203 Rep. Nolan West (R) Author, HF 4570 (companion to SF 4876 on outdoor canopy); TPII 10→35% proposal Cannabis Advisory Council OCM regularly presented developing proposals to the Cannabis Advisory Council throughout the fall 2025 engagement process, and the Council's feedback shaped the supply chain streamlining framework and medical endorsement structure. Appendix: Bill Reference Table Bill Number Topic Status (as of May 2026) SF 4403 / HF 4199 Technical/Housekeeping In Omnibus (SF 4401) SF 4402 / HF 4200 Data Practices In Omnibus (SF 4401) SF 4429 / HF 4201 Product Labeling & Hemp Regulatory In Omnibus (SF 4401) SF 4540 / HF 4398 Cannabis Business Regulatory In Omnibus (SF 4401) SF 4519 / HF 4202 Local Control In Omnibus (SF 4401) SF 4401 / HF 4203 Legislative Reporting Efficiency In Omnibus (SF 4401) SF 4541 / HF 4397 Supply Chain Streamlining Article 3, Omnibus (SF 4401) SF 4401 (Omnibus) All above consolidated Passed Senate Commerce Committee; Senate Finance Committee SF 4876 / HF 4570 Microbusiness 1-Acre Outdoor Canopy Senate: Referred to Commerce Committee (3/26/26); House: Ways & Means (pending) Federal P.L. 119-37, Sec. 781 Hemp Definition / 0.4 mg THC Container Limit Enacted Nov. 12, 2025; Enforcement effective Nov. 12, 2026 This report is for informational and strategic planning purposes. It reflects the state of legislation as of May 5, 2026, and is subject to change as the 2026 Minnesota legislative session concludes. Consult legal counsel for application to specific business circumstances.

Here’s what we know so far about the new federal medical cannabis / DEA rescheduling framework, the June 22 date, fees, federal grants, and 280E—with the important caveat that IRS/SBA implementation details are still developing. What is the June 22 DEA filing deadline? On April 22, 2026, the DOJ/DEA issued a final order that moves: FDA‑approved marijuana products, and Marijuana is handled under a qualifying state medical marijuana license from Schedule I to Schedule III of the CSA, effective immediately. For state‑licensed medical operators, DEA is creating an expedited registration pathway: State medical marijuana licensees that submit a DEA registration application within 60 days of publication (by Monday, June 22, 2026) can continue operating under their state license while the DEA reviews the application. DEA has committed to processing those “early” applications within six months. So, for a Minnesota‑style state medical operator, June 22, 2026 is the priority window to: File the appropriate DEA registration (manufacturer/distributor/dispenser) Lock in the ability to operate during review rather than having to pause operations under federal law. Initial and ongoing DEA fees DEA is applying its standard Schedule III registration fee structure to these medical cannabis registrations. Current fees are: Manufacturer (cultivator/processor in DEA terms): $3,699 annually. Also, there is a $113 per kilogram (each 35.5lbs) Distributor: $1,850 annually. Dispenser (includes pharmacies and, under this order, medical dispensaries): $888 for a three‑year registration (effectively ~$296/year). Key points: These are federal DEA fees only; they’re in addition to existing state application/license/renewal fees. As of now, no separate “one‑time” DEA application fee is described beyond the standard registration fee; the recurring fee is the main cost structure. For security/storage, DEA allows state‑licensed medical operators to meet Schedule III security obligations by complying with their state security standards, rather than stricter standalone federal build‑outs, which is a cost saver. Can medical cannabis operators use federal grants? A. General federal small‑business grants/loans The current federal posture is still restrictive: The Small Business Administration (SBA) updated guidance in 2025 explicitly stating that businesses that “grow, produce, process, distribute, or sell marijuana” are ineligible for key loan programs like 7(a) and 504. That guidance is framed broadly as “marijuana businesses,” and has not yet been revised to carve out state‑licensed medical operators under Schedule III. So as of now: Traditional SBA loans and many SBA‑linked federal financing tools remain off‑limits to plant‑touching cannabis businesses, even medical. Most general federal small‑business grants/loan guarantees follow similar controlled‑substance exclusions in their program rules, and those rules have not yet been systematically updated to reflect the April 2026 DOJ/DEA order. B. Specialized or state‑administered grants Several states run cannabis‑specific grant or loan programs (e.g., New Jersey’s Cannabis Business Development Grant, which reimburses up to $75,000 for eligible cannabis businesses). These are state programs funded and structured under state law; they are distinct from federal grants, and typically are available to licensed cannabis operators. Bottom line on grants right now: Plant‑touching medical cannabis businesses should not assume eligibility for federal grants or SBA‑style loans yet. State or local cannabis‑specific grant/loan programs may be available, and those are where the near‑term opportunity lies. Over the next 12–24 months, watch for program‑by‑program rule changes—Congress or agencies could start carving out DEA‑registered medical operators, but that has not happened broadly yet. Can medical cannabis bypass IRC 280E now? This is the biggest immediate win for medical operators. A. Why 280E no longer applies to qualifying medical cannabis IRC 280E disallows deductions and credits for businesses that “traffic in controlled substances” listed on Schedule I or II of the CSA. Moving a substance to Schedule III means it is no longer within the scope of 280E, because 280E only references Schedules I and II. The April 22, 2026 DOJ/DEA order explicitly: Places FDA‑approved cannabis products and state‑licensed medical marijuana products into Schedule III. Legal and tax analysis since the order is clear: state‑licensed medical cannabis operators are no longer subject to §280E’s deduction disallowance for those Schedule III activities. Implications: Medical operators can now deduct ordinary and necessary business expenses (rent, payroll, marketing, admin, etc.) at the federal level, like any other Schedule III business. This is a major effective‑tax‑rate reduction compared to the prior 280E treatment. B. Does DEA registration matter for 280E? Some tax and regulatory commentary flags a nuance: The rescheduling order does not clearly state that medical marijuana handled by a non‑DEA registrant is still Schedule I, but the IRS could take the position that 280E continues to apply to operators who do not obtain DEA registration, at least until guidance is clarified. Several firms are recommending that state‑licensed medical operators file for DEA registration (by June 22 if possible), both for compliance and to strengthen the case that their activities are unequivocally Schedule III. So from a risk‑management perspective: To truly “bypass 280E” in a durable way, a state medical operator should: Be operating under a qualifying state medical program, and Apply for and maintain DEA Schedule III registration appropriate to its role (manufacturer/distributor/dispenser). C. Adult‑use still stuck under 280E The order does not reclassify adult‑use cannabis; anything outside FDA‑approved products and qualifying state medical programs remains Schedule I. Adult‑use operators, therefore, remain subject to 280E until and unless DEA reschedules “marijuana as a whole” after the June 29, 2026, hearing and any follow‑on rulemaking. For mixed operators: Expect a need to segregate medical vs adult‑use operations, accounting, and entity structure if you want to clearly isolate non‑280E medical revenue from still‑280E adult‑use revenue. WHAT TO DO? Practical takeaways for you (as an advisor/operator) For a state‑license medical operator (existing or planned): File the DEA registration before June 22, 2026 Choose the correct category: Cultivation/processing → Manufacturer Distribution/wholesale logistics → Distributor Retail dispensary → Dispenser. Filing by June 22 lets you keep operating under state law while DEA processes, with a six‑month processing commitment. Budget for DEA fees and ongoing compliance Manufacturer: $3,699/year Distributor: $1,850/year Dispenser: $888 per 3 years. Leverage the rule that state security standards satisfy federal security to avoid overbuilding. Plan for 280E relief Work with tax counsel to: Model the impact of fully deductible OPEX under Schedule III. Evaluate amended returns for open years where possible. Design entity/accounting structures that separate medical from adult‑use if you’re dual‑licensed. Be conservative about federal grants/loans Assume SBA and many federal programs still treat cannabis as ineligible until official revisions say otherwise. Focus near‑term on state or local equity/cannabis‑specific grant/loan programs. Monitor the June 29, 2026, DEA hearing That proceeding will address potential broader rescheduling of marijuana as a whole to Schedule III, which could eventually extend 280E relief and banking/grant changes to adult‑use as well.

For a cultivation‑only microbusiness (grow + wholesale) with outdoor canopy in Minnesota in 2026, a realistic planning range is: Startup (before first harvest): about $200,000–$450,000 Ongoing annual operating costs: about $100,000–$200,000/year That assumes up to ½ acre of outdoor canopy, using leased rural land, no retail build‑out, and selling wholesale to other licensees. Below is a more tailored budget for that scenario, including fees and taxes (“tariffs”) that actually apply. License & regulatory costs (cultivation‑only microbusiness) Even if you only cultivate and wholesale, you still hold a microbusiness license, but simply don’t use the manufacturing/retail endorsements. State license fees (microbusiness) From statute and OCM guidance: Application fee (one‑time): $500 Initial license fee (covers first year): $0 Annual renewal fee (from year 2 onward): $2,000/year So, regulatory cash outlay to get licensed is very low compared to your build‑out. Local government & permitting Even cultivation‑only will require: Zoning / land‑use approvals (conditional use permit, site plan, etc.): Budget $1,000–$5,000 for application fees, mailings, hearings (varies by county/city). Building, electrical, and possibly well/septic permits for fencing, storage shed, irrigation, and power improvements: Commonly $2,000–$10,000 depending on scope. Because you’re not doing retail, you do not need a local retail registration, which avoids the local retail registration fees and the cap/lottery risk for retail slots. Site, security, and infrastructure (½‑acre outdoor) Legally compliant outdoor cultivation must be fenced, secured, and have appropriate utilities and environmental controls for drying/storage—this is where most of your capital will go. Land / lease For leased rural land within a reasonable distance of the Twin Cities: Expect $5,000–$20,000/year for a few acres with road access, room for parking, and space for your fenced ½‑acre grow, storage, and turnaround. (Land value varies widely; this focuses just on the cannabis‑relevant budget.) If the landlord isn’t cannabis‑friendly or wants a risk premium, that may skew higher. Fencing & security Outdoor cultivation areas must be enclosed and secured to prevent unauthorized access. For roughly ½ acre: ½ acre ≈ 21,780 sq ft. A compact rectangle (e.g., 120 ft x 180 ft) gives about 600 linear feet of fence. Security fence (6–8 ft, posts, two secure gates, installed): $20,000–$40,000 depending on contractor and terrain. State‑compliant security system: Cameras, NVR, data storage, lighting, alarms, signage: $10,000–$25,000 for a small but compliant outdoor operation plus storage building. Water & irrigation Rules require documented plans for electricity, water, wastewater, and solid waste for cultivation. For a ½‑acre outdoor grow: Drip irrigation system (pump, header lines, drip tape/emitters, filtration, controllers): $5,000–$15,000 Water source: If tapping an existing well or municipal feed nearby, allow $5,000–$15,000 for plumbing, backflow prevention, and permits. If drilling a new well: $10,000–$30,000, depending on depth. Power & basic structures Even outdoor grows need power for: Security system, cameras, and internet uplink Drying room fans, dehumidifiers, heaters Small tools & lighting Typical costs: New or upgraded electrical service / trenching from road or house: $5,000–$20,000 (highly site‑dependent). Small storage + drying building (e.g., 400–1,000 sq ft insulated pole barn or prefab shed) with minimal interior finish: $25,000–$75,000 depending on size and finish. Drying/curing equipment (fans, racks, dehumidifiers, small heaters): $5,000–$15,000 Site prep Ground preparation (tilling or ripping, soil testing, amendments, raised beds or rows, erosion control): $10,000–$30,000 first year. Driveway/parking improvements and basic stormwater management (if required): $5,000–$20,000 depending on existing conditions. Reasonable planning range – site & infrastructure for cultivation‑only outdoor microbusiness:~$80,000–$200,000 if you already have water/power close by and build modest structures; $200,000–$250,000+ if you need a new well, major power extension, and a larger building. Cultivation equipment & inputs (first season) For a ½‑acre, single‑harvest, outdoor field: Genetics & inputs Seeds / clones: A ½‑acre grow at outdoor spacing (say 4–6 ft centers) might run 600–1,200 plants. At $5–$20 per plant equivalent, budget $5,000–$15,000. Soil amendments & fertilizers (organic or conventional within state rules): Compost, lime/gypsum, base fertilizer, top‑dress: $10,000–$25,000 first season. Pest & disease control (IPM program): Approved pesticides/biocontrols, sprayers, scouting: $5,000–$15,000. Tools, small equipment, and consumables Trellis/netting, stakes, drip repairs, shade cloth (spot use), hand tools, PPE, bins/totes: $5,000–$10,000 Harvest & trim tools, tables, racks, scales, labelers: $5,000–$15,000 Vehicle(s) If you don’t already have a suitable farm truck or van: Used pickup/van for on‑site use and moving materials: $15,000–$40,000 depending on age/condition. Note: transport of cannabis between licensees normally must be done by or under a licensed transporter, so your own vehicle use is mostly on‑site or between your own locations. Reasonable planning range – equipment & inputs (year 1):~$40,000–$100,000 (higher end if you buy a dedicated vehicle and premium genetics). Labor & operating costs (annual, cultivation‑only) Labor For ½ acre outdoor, cultivation‑only: Owner‑operator: Many people effectively pay themselves last. One full‑time grower/lead (if not you): $45,000–$65,000/year plus payroll taxes/benefits. Seasonal labor for planting, training, harvesting, and trimming: 2–4 seasonal workers, part‑time/short‑term around peak periods: $20,000–$60,000/year total cash payroll, depending on wage rates and how much you outsource trimming. Compliance, admin & insurance Bookkeeping, payroll, seed‑to‑sale tracking, SOP maintenance: Software plus external support: $5,000–$15,000/year. General liability, product liability (once selling flower/biomass), property/crop insurance: $10,000–$30,000/year, depending on coverage and insurer appetite. Utilities, testing, and other operating expenses Utilities: power for cameras/drying, water pumping, internet for security feed – typically $5,000–$15,000/year for a modest facility. Lab testing: each harvest batch must be tested for potency and safety; for a small outdoor grow with a handful of distinct batches, plan $5,000–$10,000/year. Repairs, maintenance, and consumables: Replacing drip lines, nets, hand tools, PPE, fuel: $5,000–$15,000/year. Reasonable planning range – annual operating costs (excluding owner draw and debt service):~$100,000–$200,000/year for a compliant ½‑acre cultivation‑only microbusiness. Taxes and “tariffs” that hit a cultivation‑only operation State & local cannabis taxation As a cultivation‑only microbusiness: You sell wholesale to processors/retailers; you are not charging retail sales tax directly. Minnesota’s cannabis‑specific excise tax is collected at retail; it influences what retailers can pay you (since their out‑the‑door price must cover both wholesale cost and taxes). Normal state income tax applies to your net income, subject to 280E constraints below. Federal tax – IRC §280E (the big “tariff”) Even though you’re only cultivating and wholesaling, at the federal level you are still “trafficking” in a Schedule I substance. This means: You may deduct COGS (cost of goods sold) – things directly tied to production. You cannot deduct much of your overhead (administrative salaries, marketing, much of rent, interest, many G&A items) for federal income tax. Result: Your effective federal income tax rate on actual economic profit can be much higher than for a normal farm—often 40–70% of taxable income once 280E disallows deductions. This is not a customs tariff, but functionally acts like one by taking a large slice of any profit. Customs tariffs (real “tariffs”) You won’t be importing cannabis, so there are no cannabis‑specific import tariffs. If you directly import equipment (e.g., greenhouse frames, fertigation hardware) from overseas, normal U.S. customs duties apply—but most small operators buy through U.S. distributors, and the tariff is built into purchase price. Regulatory and inspection charges Background checks, any future per‑license assessments, plus your $2,000 annual state license renewal, are smaller but real line items. As a rough rule, it’s prudent to assume that 15–25% of your eventual, steady‑state cash profit is going to disappear in some combination of cannabis‑specific taxes (indirectly via wholesale pricing), regular income taxes, 280E impact, license renewals, and compliance‑related testing/fees. Putting it together – realistic budget bands for your case For a cultivation‑only, outdoor microbusiness (½ acre) on leased rural land near the Twin Cities, here are three realistic bands: Scenario Key assumptions Startup (before first harvest) Annual OpEx after year 1* Lean Existing well/power; modest fence, small dry room; owner is the main labor; used truck $200k–$275k $100k–$130k Moderate Some utility upgrades; nicer fence & security; 600–800 sq ft dry building; some hired labor $275k–$375k $130k–$170k Robust New well and power run; larger insulated building; higher‑end security; more hired staff $375k–$450k+ $170k–$200k+ *Excludes owner salary and loan interest; both depend on your financing structure. These ranges line up with Minnesota‑specific microbusiness startup analyses that show $150k–$350k+ for minimal microbusiness setups, with outdoor‑only cultivation cases typically clustering in the lower to mid part of that range once you strip out retail build‑out. Need Help on Your're Project? We Got You...

The federal rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) is a significant — but widely misunderstood — policy shift. As of April 2026, the process is still ongoing: President Trump signed Executive Order 14370 in December 2025, directing the DEA to expedite rescheduling; the DEA issued a Notice of Proposed Rulemaking in February 2026, the public comment period closed April 15, 2026, and a final rule is not expected until late 2026 or early 2027 at the earliest. For now, only medical cannabis will be able to take advantage of Schedule III benefits over normal business owners still operating under Schedule I The core message: Schedule III is not legalization. It is a federal reclassification that changes the government's official stance on cannabis's medical value and abuse potential — and most critically, eliminates the punishing 280E tax burden — but leaves the broader legal landscape for state-licensed cannabis businesses largely intact. Where the Process Stands in April 2026 The rescheduling process has moved faster under Trump's executive order, but multiple procedural and legal hurdles remain: December 18, 2025: EO 14370 signed, directing expedited rescheduling February 1, 2026: DEA issued Notice of Proposed Rulemaking April 15, 2026: Public comment period closed (~40,000 submissions) April 23, 2026: President Trump reclassifies only Medical Cannabis companies. June 29, 2026: an expedited administrative hearing will begin to consider broader rescheduling from Schedule I to Schedule III, in addition to big medical. An interlocutory appeal that had previously stalled the DEA hearing process appears to have been resolved by Trump's executive order and the new proposed rulemaking, but additional legal challenges from parties opposed to rescheduling remain possible. Under the Congressional Review Act, once a final rule is published, Congress has a 60-day window to pass a resolution of disapproval. Given current political dynamics, this is considered unlikely — but it represents one more procedural layer before rescheduling becomes fully effective. What the Schedules Actually Mean Under the Controlled Substances Act, all controlled substances are placed into one of five schedules based on two factors: accepted medical use and potential for abuse or dependence. Schedule Medical Use Abuse Potential Examples I (current) None accepted High Heroin, LSD, MDMA II Accepted High Cocaine, fentanyl, methamphetamine III (proposed) Accepted Moderate-to-low Ketamine, anabolic steroids, Tylenol w/ codeine IV Accepted Lower than III Xanax, Valium, Ambien V Accepted Lowest Cough syrups with codeine Moving cannabis to Schedule III means the federal government formally acknowledges it has accepted medical use and moderate-to-low dependence potential — a dramatic shift from 50+ years of Schedule I status alongside heroin. The rescheduling was supported by scientific and medical evaluation from HHS, with the National Institute on Drug Abuse concurring in the recommendation. What Actually Changes The 280E Tax Relief — The Biggest Deal This is the single most consequential change for cannabis operators. Under Internal Revenue Code Section 280E — enacted in 1982 — any business "trafficking" in Schedule I or II substances is prohibited from deducting ordinary and necessary business expenses on federal taxes. The practical impact is brutal: cannabis operators pay federal income tax on gross income rather than net profit. While the cost of goods sold (COGS) remains deductible, expenses like payroll, rent, marketing, insurance, utilities, and professional services are not. The result is effective federal tax rates that routinely exceed 70% for cannabis businesses — versus the ~21% corporate rate other industries pay. Because 280E only applies to Schedule I and II substances, rescheduling to Schedule III removes cannabis from 280E's scope entirely. Once effective, cannabis operators could: Deduct ordinary and necessary business expenses (payroll, rent, marketing, insurance) Access standard business tax credits Report net income instead of gross income for federal tax purposes Align their effective tax rates with those of other legitimate industries Industry experts describe this as potentially "the difference between survival and investment" for plant-touching operators. For a microbusiness or mezzobusiness running on thin margins, the cash flow improvement could be transformational. It's worth noting that some tax professionals believe the government may attempt to find alternative ways to retain 280E-level tax revenue from the cannabis industry, though this is speculative. One important timing note: 280E relief would apply beginning in the tax year the final rule takes effect — not retroactively. Operators should not amend prior-year returns preemptively. Enhanced Research Opportunities Schedule I status has been the primary reason U.S. cannabis research has lagged behind other countries. Under Schedule I, researchers face extraordinary DEA licensing requirements, limited supply access, and institutional reluctance to fund studies. Schedule III meaningfully lowers these barriers. It opens pathways for universities, biotech companies, and pharmaceutical firms to study cannabis-derived compounds under standard drug development models — including expanded clinical trials, licensing agreements, and institutional investment in cannabinoid therapeutics. The Trump executive order specifically emphasized facilitating medical research and CBD access as core goals. This is likely a bigger win for Big Pharma than for state-licensed dispensaries — companies with the resources for FDA approval processes stand to benefit most from a more permissive research environment. Reduced Stigma and Investor Confidence A formal federal acknowledgment of cannabis's medical legitimacy lowers perceived legal and compliance barriers for many financial institutions and institutional investors who were previously sidelined by Schedule I. This means: More willingness from banks to engage with cannabis businesses (even if not guaranteed) Exchanges are becoming more receptive to cannabis company listings Traditional institutional investors re-entering the space Improved valuations and M&A activity as the industry becomes "less toxic" to mainstream capital Some Criminal Penalty Reduction Schedule I carries certain unique criminal penalties and advertising restrictions that would no longer apply under Schedule III. However, this is narrower than it sounds — many CSA provisions specifically target marijuana regardless of its schedule, and most criminal penalties remain intact. Prior convictions are not affected by rescheduling. What Does NOT Change This is where widespread public confusion occurs. Here is what Schedule III does not do: State-Licensed Cannabis Remains Federally Illegal The most important misunderstanding: rescheduling does not make state-licensed dispensary sales federally legal. Cannabis businesses — including Minnesota microbusinesses, mezzobusinesses, and retailers — would still be operating outside any federal licensing framework. The DEA could theoretically still enforce federal law against state-legal operators. No Interstate Commerce Interstate cannabis sales remain prohibited. Under Schedule III, interstate commerce is limited to FDA-approved drugs. State-licensed cannabis products are not FDA-approved medications. Moving product across state lines remains a federal crime. Banking Access Remains Limited for Small/Medium Non-Medical Businesses Schedule III does not resolve the fundamental banking problem. Banks remain exposed to potential money laundering charges, loss of FDIC insurance, and regulatory action for processing proceeds from cannabis sales — because the underlying activity is still federally illegal outside FDA-approved channels. The SAFER Banking Act, which would provide an explicit federal safe harbor for banks serving state-legal cannabis businesses, remains the clearest path to meaningful banking reform — and it has not passed. What may improve: some smaller banks and credit unions operating under state jurisdiction, payment processors, and alternative financial services may become slightly more willing to serve cannabis clients as compliance risk perception decreases. ACH payment systems are already seeing increased adoption — nearly 42% of cannabis transactions are projected to run on ACH rails in 2026, up from 28% in 2025. But Schedule III alone does not open the floodgates. Credit Cards Still Off-Limits Card network rules (Visa, Mastercard) prohibit credit card acceptance for plant-touching cannabis businesses regardless of federal scheduling. This is a card network policy issue, not solely a federal law issue. Doctors Still Cannot "Prescribe" Cannabis Federal prescriptions require FDA-approved drugs dispensed through DEA-registered pharmacies. Cannabis products sold in state dispensaries are not FDA-approved. Medical access remains certification-based under state law. Patients cannot take a federal prescription to a state dispensary as things stand. Federal Benefits and Employment Restrictions Remain Federal housing assistance, federal employment background checks, firearm purchasing questions (ATF Form 4473), and other federal benefit restrictions tied to drug use remain largely intact. Unprescribed recreational use remains federally illegal. No Effect on State Law Rescheduling does not affect state cannabis laws — in either direction. States with adult-use markets (like Minnesota) remain fully operative under state authority. States that ban cannabis remain free to do so. The FDA Regulatory Wild Card One underappreciated complexity: Schedule III activates FDA regulatory authority in a way that was largely dormant under Schedule I. The FDA published guidance in March 2026 outlining how it would regulate cannabis products under Schedule III, including pathways for pharmaceutical cannabis products. This creates a significant open question for the state-licensed industry: will the FDA begin treating cannabis like other Schedule III drugs, requiring manufacturers and retailers to hold DEA licenses and requiring products to undergo the FDA approval process before being marketed? If so, this could create a massive compliance burden for the existing industry. Current FDA-approved cannabinoid products — Epidiolex (CBD for seizures), Marinol/Syndros, and Cesamet — all went through the full FDA approval process and are only available by prescription through licensed pharmacies. The FDA has historically maintained that cannabinoids cannot be added to foods or marketed as dietary supplements where the active ingredient has already been approved as a drug, and Schedule III does not resolve this conflict. The most likely outcome is a two-track system: FDA-approved pharmaceutical cannabinoids on one track, and state-regulated products on another track that the federal government tolerates without formally authorizing. But the boundaries of that tolerance remain undefined. Implications for Minnesota Cannabis Operators For Minnesota microbusiness and mezzobusiness operators, the practical near-term implications break down as follows: Area Impact When Final Timeline 280E tax relief High — deduct payroll, rent, marketing, etc. Tax year final rule takes effect Banking access Low-to-moderate — SAFER Banking Act still needed Uncertain State licensing/operations None — OCM rules unchanged N/A Interstate commerce None — still prohibited N/A Capital access/investment Moderate — reduced stigma for investors Gradual, ongoing Research pathways Moderate — benefits larger operations/pharma more Gradual, ongoing Criminal risk Slight reduction in some penalties When final rule effective The most actionable preparation for operators right now: Work with a CPA familiar with cannabis tax law to model the impact of 280E relief on your specific cost structure and prepare for the transition once a final rule is effective Do not restructure operations prematurely based on an unfinalized rule — the final rule could face further delays or legal challenges Monitor the SAFER Banking Act progress separately, as banking reform is the bigger operational unlock for daily operations. Or just have us do it. Understand that your state licenses and compliance requirements are unchanged — OCM rules are the governing framework, regardless of federal scheduling

A Minnesota cannabis retailer should treat 4/20 as a full campaign: use the weekend before to build anticipation and capture contact info, turn 4/20 itself into a high‑energy, compliant in‑store event, then run a structured 4–6-week retention plan to convert first‑time visitors into regulars. Creative Network's complete framework overview on loyalty programs, gifting, etc. Stay within Minnesota Rules Minnesota law prohibits giving cannabis flower or cannabis products as free samples or promotional gifts if you are in the business of selling goods or services, including in connection with other purchases, so avoid “free pre‑roll with every T‑shirt” or similar offers. At licensed cannabis events, retailers may not give cannabis flower or cannabis products to attendees for no remuneration, so “free weed” at events is not allowed either. Public cannabis use is allowed only in limited locations (private residences, certain private property, or licensed consumption events), and on‑site consumption events require a cannabis event organizer license, local government approval, 21+ access, and no alcohol service. Advertising cannot target people under 21, promote overconsumption, or use many mass channels (e.g., certain billboards, pop‑up ads), but age‑gated email, websites and other digital channels are allowed; discounts and promotions (percentage‑off, bundles, loyalty) are generally allowed as long as there are no free samples and products are not sold below defined “market value.” Local governments may add zoning, sign, and retail registration requirements, so check Vadnais Heights’ or your city’s ordinances and registration process alongside state rules. Use these guardrails as a filter: every 4/20 idea should be exciting but clearly legal and adult‑focused. Key Goals for the 4/20 period Drive traffic and basket size on 4/20 and the surrounding weekend. Grow your first‑party audience (email/SMS list, loyalty members) in a compliant way. Deliver a memorable in‑store experience, so first‑time shoppers associate you with education, safety, and fun, then give them clear reasons to come back. Weekend before April 20 Focus on building anticipation, smoothing operations, and collecting opt‑ins. Launch a “420 countdown” with daily or weekend‑only specials by category (e.g., “Flower Friday,” “Edibles Saturday,” “Wellness Sunday”) using standard discount types common in MN, such as daily specials, new‑customer discounts, bundles, and loyalty offers. Promote these offers through age‑gated email, SMS, and your website; avoid broad social ad targeting or placements where more than 15% of the audience may be under 21. Offer 4/20 preorder bundles (no free product, just value pricing) to help forecast demand and reduce day‑of bottlenecks. Train staff on ID checks, safe‑use education, and upselling bundles, and ensure you meet background‑check and documentation requirements for employees. Set up in‑store education touchpoints (simple dosing guides, “start low, go slow” signage, brief “Ask a budtender” Q&A times) to differentiate on responsibility, not hype. On April 20 (and that weekend) Design the day as a peak experience that stays within the event and promotion rules. Create a 4/20 in‑store theme (decor, music, photo backdrop) and give away non‑cannabis swag like branded lighters, rolling trays, stickers, or T‑shirts instead of any free cannabis. Run time‑boxed specials to spread traffic (e.g., “early‑bird 10–15% off select categories in the morning, afternoon ‘happy‑hour’ bundles”), keeping discounts within allowed promotion structures. Add a “420 New Shopper” station that quickly signs people up for your loyalty program or email list at checkout, clearly disclosing that communications are for adults 21+ and compliant with marketing rules. Partner with nearby non‑cannabis businesses (coffee shop, food truck, record store) for cross‑promotions—such as mutual coupon handouts—without mixing cannabis into food or beverages, which remains prohibited. If you participate in or host a consumption‑friendly event, do so through a properly licensed cannabis event organizer: events must be 21+, have local approval, fenced consumption areas, and no alcohol, with secure product storage and limited‑access areas. Operationally, plan for extended hours, extra staff, additional POS stations, clear queue management, and streamlined online ordering plus in‑store pickup. Post‑420 Retention (Next 4–6 weeks) Convert 4/20 traffic into repeat visits and higher customer lifetime value. Award extra loyalty points or tier boosts for purchases made on 4/18–4/20, and send a follow‑up “thank you” message with a bounce‑back offer (e.g., “Return within 30 days for X% off a regularly priced item”) that complies with your discount policies. Build a short onboarding sequence for new customers: 2–3 educational emails or texts over the next month with product guides, safe‑use tips, and upcoming low‑key events (e.g., “Edibles 101 night,” “Terpene tasting” without on‑site consumption). Ask for reviews and referrals in your follow‑up communication and consider referral rewards in the form of allowed discounts or loyalty points, not free cannabis. Use your sales data from 4/20 to segment customers by product preference (flower vs. edibles vs. vapes vs. topicals), then run rotating weekly specials tailored to each segment. Schedule recurring “micro‑events” (non‑consumption education nights or vendor spotlights) to keep your brand top‑of‑mind without relying on large, heavily regulated consumption events. Quick 4/20 Action Plan Chart Timing Objective What to Do (MN‑compliant) 1–2 weeks before 4/20 Plan, ensure compliance, tease offers Confirm local registration/zoning; review OCM guidance on events, promotions, no‑free‑weed rules; draft 4/20 specials calendar and submit anything complex for legal review if needed. Weekend before 4/20 Build buzz and grow your list Run “countdown” category specials and preorder bundles; promote via age‑gated email/SMS and website; train staff on ID checks and safe‑use education; set up easy loyalty/email sign‑up at POS. 4/18–4/20 in‑store Maximize traffic and experience Themed decor and non‑cannabis swag; time‑boxed discounts, bundles, and loyalty boosters (no free cannabis); optional participation in licensed 21+ cannabis event with secure storage and no alcohol if you want on‑site consumption. Week after 4/20 Get a fast second visit Send “thank you” messages to 4/20 shoppers with bounce‑back offers valid 2–4 weeks; highlight one or two hero products and reinforce responsible use. Weeks 2–6 after 4/20 Build long‑term loyalty and frequency Run segmented weekly specials based on purchase data; host small education‑focused events (non‑consumption unless fully licensed); keep educating via email/SMS, and invite reviews and referrals with compliant incentives. This framework keeps you inside Minnesota’s legal lines while still making 4/20 a tent‑pole sales and branding moment that feeds a longer‑term customer strategy. Need additional help or want a copy of the PDF overview? Reach out.

You should bring all seed genetics into Metrc as packages of seeds , then only “plant” (convert) portions of those packages into immature plant batches as you need them, leaving the rest in inventory as seeds for later use. Want a step-by-step process on how to do this? Reach out to info@carpfishcreative.com Big picture In MN, all beginning inventory must be in Metrc within your first 30 days as either plants or packages. Seeds enter Metrc only as packages , not as plants. Plants always start in Metrc as “immature plant batches” created from those seed packages. You are allowed to keep seed packages in inventory and draw down from them over time; only the seeds you actually plant need to be turned into immature plant batches. Step-by-step: how to set it up 1. Enter all seeds during the 30‑day window For each strain you currently possess in seed form, do this before your 30 days ends: Create an external incoming transfer in Metrc to bring in your seeds as packages (this is the required method for beginning inventory seeds). For each strain/lot, create a package with: Item: something like “Cannabis Seeds – [Strain]” Quantity: total number of seeds you physically have for that strain Unit of measure: each/units (as per your items setup) Package tag: Assign a unique Metrc package tag and physically label that seed container with that tag. If you want to keep genetics separate (e.g., different breeders or lots of the same strain), give each its own package/tag now. Result: after day 30, Metrc shows all your seed genetics as active packages, but none are planted yet. 2. Plant only what you want now When you’re ready to start a run of a particular strain: Go to the Packages grid, select the seed package for that strain, click Create Plantings . In the Create Plantings window: Plant type: Immature Immature batch name: best practice is “Strain + planting date” (e.g., “Gelato 4.10.26”). Quantity: the number of seeds you are actually germinating this time (e.g., 25 out of a 100‑seed package). Strain: select the strain. Location/room: your nursery/veg room. Planting date: actual date you plant. Metrc will then: Create an immature plant batch for that strain/planting, Reduce the quantity of seeds left in the original package by the number you just planted. Your remaining seeds stay as a seed package in inventory, visible and compliant. 3. Use the remainder later Whenever you want to plant more of that strain in the future (after your 30‑day window has closed): Repeat the Create Plantings action from the same seed package, using a new batch name and planting date, and the quantity you’re planting that round. Do this until the seed package quantity goes to zero. Because the genetics were brought in during the initial window, you are not invoking the “new genetics” workflow; you’re just drawing down an existing, authorized seed package over time. Key compliance points for MN MN guidance: “All plants must enter the system as immature plant batches, whether sourced from clones or seeds. Seeds will be brought in via packages.” You have 30 days from credentialing to get all existing seeds into Metrc; after that, new genetics require the specific “New Genetics Workflow” and OCM approval. If you plan on storing seeds (not planting them immediately), they should remain as seed packages in inventory and not be converted into immature plants until actually planted. Make sure the physical labels on your seed containers match the Metrc package tags and descriptions. Practical tips with 100+ strains Create a simple naming convention for items and packages, e.g., Items: “Seed – [Strain] – [Breeder]” Package tag description or internal note: include lot info and count. If a strain has a large number of seeds, consider splitting into multiple packages (by lot or storage container) to give you more flexibility and cleaner audit trails later. Keep a simple spreadsheet mirroring your Metrc seed packages: tag, strain, breeder, quantity, storage location. It makes later plantings easier to plan and explain during inspections. New Genetics Workflow (Entering seeds after 30 days) For seeds acquired or added after the 30‑day window: Request approval from OCM All requests to bring in new genetics (seeds/clones) must be approved by the Office of Cannabis Management. You email OCM (address in MN_IB_0056 and the guidance memo) describing the genetics, source, and that you want the “New Genetics” external transfer type enabled. OCM/Metrc enable “New Genetics” transfer type The external transfer type “New Genetics” is disabled by default and is only turned on for you if OCM approves the request. Create an Incoming External Transfer in Metrc Go to Transfers → External → Incoming → New Transfer. Set Type = New Genetics . Planned Route field: If bought seeds from a commercial seed seller: “Bought from seed seller. Verified by the Metrc Admin.” (language from the bulletin). If it’s your own internal genetics (e.g., seeds you created): the route can simply state they came from the cultivator, per bulletin examples. Enter the item, quantity of seeds, and other required info, then submit/receive the transfer so it becomes a seed package in Metrc. Plant from that package like normal Once the package is created, you convert seeds to immature plant batches using Create Plantings from the package. From there, they move through veg/flower/harvest the same as genetics you entered in your initial 30‑day window. Practical implications for you You cannot just “late‑enter” old seeds after day 30 without using the New Genetics process and OCM approval; the beginning‑inventory path is closed. Strategically, you want all legacy / “must‑keep” genetics into Metrc during the 30‑day window so you avoid needing New Genetics approval for them later. After 30 days, treat any additional/unlisted strains as new genetics and plan on: Emailing OCM with strain details and source, Waiting for them to authorize New Genetics external transfers on your account, Then creating the external incoming transfer and seed package as described. If you tell me whether these “after 30 days” seeds are (1) truly new purchases from a seed seller, or (2) older legacy packs you just didn’t enter, I can help you script the exact email language to OCM that fits your situation. Need help from our nerds to get this squared away the right way out of the gate? Then we should talk!

You apply for LPHE retailer, manufacturer, or wholesaler licenses through OCM’s Accela online portal starting April 1, 2026, and applications are reviewed and issued on a rolling basis.mn +2 Step 1: Decide license type(s) LPHE retailer: Sells compliant lower‑potency hemp edibles to consumers; must also obtain a local retail registration before starting sales. pdf.pdf mn+1 LPHE manufacturer: Produces LPHE products and may need extraction/edible handler endorsements depending on activities. mn pdf.pdf LPHE wholesaler: Buys LPHE and hemp‑derived products from licensed businesses and sells to retailers and others; endorsements required for importing certain products. pdf.pdf mn Step 2: Prepare core documents For all three LPHE license types you should have ready before you start the online application:mn+2 Proof of trade name registration from the MN Secretary of State. Valid government‑issued photo ID for the applicant or controlling person. Site, Security, and Operations Final Plan of Record (FPOR) for each business location (covers layout, security, storage, operations, and compliance).mn+1 Any required labor peace agreement (LPA) attestation (mandatory for LPHE manufacturers under statute; recommended to confirm current OCM guidance for retailers/wholesalers).mn+1 pdf.pdf Step 3: Create / log into Accela account Go to OCM’s business licensing page and follow the link to the OCM Accela Citizen Portal. OCM_Citizen_Portal_Application_Creation_User_Guide_tcm1202-669479.pdf mn+1 Register for an account (or use the same one you used for prior hemp/LPHE or social equity processes), then sign in. OCM_Citizen_Portal_Application_Creation_User_Guide_tcm1202-669479.pdf From the home screen choose “Create an Application,” expand “Hemp / Lower‑Potency Hemp” and select the specific LPHE license type (retailer, manufacturer, or wholesaler).mn+1 Step 4: Complete the LPHE application in Accela You will go through these main sections for each license type:mn+2 Applicant and contacts Enter legal business name, DBA, tax ID, and contact roles (applicant, owner, authorized agent). OCM_Citizen_Portal_Application_Creation_User_Guide_tcm1202-669479.pdf mn Business information and activities Indicate LPHE products you’ll handle, business activities (e.g., retail, manufacturing, wholesaling, delivery, on‑site consumption), and any desired endorsements (retailer operations, delivery, on‑site consumption, edible handler, importer, etc. depending on license type). mn pdf.pdf mn Location and FPOR Provide the address and legal property description for each site, plus your finalized Site/Security/Operations plan for that location. pdf.pdf mn+1 Supporting documents Upload required PDFs (trade name registration, photo ID, FPOR, LPA attestation if required, and any additional documents listed in the LPHE Application Review and Eligibility Guidance).mn+2 Certifications and fee payment Check all acknowledgement boxes, review your entries, then pay the non‑refundable application fee via card or ACH.mn +1 OCM_Citizen_Portal_Application_Creation_User_Guide_tcm1202-669479.pdf Once payment is processed, your application is formally submitted and visible in your Accela account with a record number. mn OCM_Citizen_Portal_Application_Creation_User_Guide_tcm1202-669479.pdf Step 5: OCM review and license issuance Beginning April 1, 2026, OCM accepts LPHE retailer, manufacturer, and wholesaler applications continuously and reviews them for minimum eligibility using the LPHE Review and Eligibility Guidance.mn +3 If your application meets requirements, OCM issues your LPHE license; you can view and print the license for each approved site in your Accela attachments.mn +1 LPHE licenses are not transferable; ownership changes require a new license, not a simple update. mn pdf.pdf Extra step for LPHE retailers: Local retail registration After you receive your state LPHE retailer license, you must obtain a local retail registration from your city or county before starting LPHE sales. OCM_Qualified_Applicant_Guide_tcm1202-669481.pdf mn pdf.pdf mn Local governments cannot cap the number of LPHE retail registrations, but they can impose zoning, permitting, and compliance requirements you must satisfy.lmc+1 pdf.pdf If you tell me whether you are pursuing retailer, manufacturer, or wholesaler (and your city), I can list the exact documents and endorsements you should line up for that specific application.

You have two main pathways in Minnesota: build the lounge into a cannabis microbusiness with on‑site consumption, or obtain an on‑site consumption endorsement for another qualifying license type once OCM finishes rules and your city allows it. Below is the practical breakdown.revisor.mn +2 Clarify your license path Minnesota law currently only clearly authorizes on‑site consumption lounges as an endorsement tied to specific license types, not as a completely free‑standing “hookah‑style” lounge.mn +2 A cannabis microbusiness  that operates a retail location may be endorsed for on‑site consumption of edible cannabis products and lower‑potency hemp edibles  on part of its premises.mncannabiscollege+2 Retailers / mezzobusinesses are expected to be able to get similar on‑site endorsements once rules are fully in place, but it is still subject to OCM rulemaking and local approval.revisor.mn +2 If you tell me whether your retail license is a micro, mezzo, or straight retailer, I can tailor this to your exact situation. Know what kind of “lounge” is allowed Minnesota’s on‑site consumption model is much closer to an edibles café than a smoking lounge.minneapolismn+2 Indoor smoking or vaping of cannabis is banned by the Minnesota Clean Indoor Air Act in essentially all public indoor spaces, including cannabis businesses. minneapolismn For microbusiness on‑site consumption: Only edible cannabis products and lower‑potency hemp edibles  may be consumed on‑site.codelibrary.amlegal+1 Smoking or vaping any  cannabis, hemp, or tobacco products on the premises is prohibited.revisor.mn +1 Products sold for on‑site consumption cannot be removed from the designated on‑site area. codelibrary.amlegal+1 Cities may  allow outdoor on‑site consumption in the future, but those licenses and local rules are still emerging.lmc+1 State‑level steps for an on‑site lounge At the state level, think of this as your existing retail license plus an “on‑site consumption” endorsement. Check your license type on the OCM license types page to confirm if you’re eligible for on‑site consumption and what endorsement is required.mn +1 Prepare an operations plan specific to the lounge: Floor plan clearly marking a definite and distinct  on‑site consumption area, separate from general retail, with its own entrance.revisor.mn +1 Age‑restriction controls so only 21+ enter the consumption area.mn +1 Security, surveillance (24‑hour video), and access control, integrating the lounge space with your existing system.treez+1 Update your compliance documentation for OCM: Inventory and POS procedures for products that are “for on‑site use only” and cannot leave the area. codelibrary.amlegal+1 Packaging/labeling and testing documentation for all edibles consumed on‑site in line with Chapter 342 and OCM rules.mn +1 Once OCM formally opens applications for on‑site endorsements, you’ll submit an endorsement application (likely amendments to your existing license file) with the above plans.revisor.mn +1 Local zoning and approvals Even with state authorization, your city has to allow the lounge. Minnesota gives cities broad power over zoning, setbacks, and whether to allow on‑site consumption at all.mn +1 Some cities (for example, Little Falls) have already adopted detailed ordinances mirroring the state on‑site rules (distinct entrance, no smoking/vaping, no removal of product, etc.). codelibrary.amlegal You will typically need: Zoning confirmation that “on‑site consumption” is a permitted or conditionally permitted use at your retail location. In many cities, a conditional use permit or specific “on‑site consumption endorsement” at the local level, with a public hearing.mn +1 Start early with your city planner and city attorney; bring them the statutory language in 342.28 so they see that you are proposing the regulated micro‑style model, not an uncontrolled smoke lounge.lmc+1 Physical build‑out requirements Plan your build‑out to satisfy both OCM and your local building/health departments. Clearly separated lounge area: Walls or a strong partition from general retail, and a separate door that can be controlled for ID checks.revisor.mn +1 Clear signage for 21+ only and for “no smoking or vaping” consistent with the Clean Indoor Air Act.minneapolismn+1 Security and monitoring: Camera coverage of all access points and the interior of the consumption area, recorded and stored per OCM rules.treez+1 A layout that allows staff to visually monitor the space without creating blind spots. treez If you intend to serve food/non‑infused beverages: You must meet all standard restaurant/food‑service codes in your city and county health department, in addition to cannabis rules.mn +1 Because smoking is off the table indoors, you generally do not need a “hookah‑level” negative‑pressure room, but odor control from the retail side and any adjacent outdoor areas is still important for nuisance standards.minneapolismn+1 Operational rules for the lounge You will need a tightly written SOP set just for the lounge. ID and entry: Check ID at the lounge entrance; no minors, even if they are medical patients through your other operations.revisor.mn +1 Product handling: Only products you sold from your licensed premises may be consumed there; no outside products.codelibrary.amlegal+1 Serve edibles in a way that keeps packaging and dosing information visible to the consumer.mn +1 Dosing controls and over‑intoxication: Written policies for maximum per‑visit sales for on‑site consumption, staff training to recognize over‑consumption, and procedures for refusing further service.revisor.mn +1 No alcohol and no tobacco: Adult‑use cannabis lounges cannot operate as a bar; alcohol service is prohibited.treez+1 Tobacco use is also barred by the Clean Indoor Air Act.minneapolismn+1 This all needs to sync with your retail SOPs (METRC/inventory, cash handling, incident reporting). Timeline and “what you can do now” OCM is still rolling out full adult‑use rules and endorsement processes, and in the meantime on‑site edibles consumption is mainly limited to existing on‑sale liquor establishments serving lower‑potency hemp products.lmc+1 In practice, you can start now by: Choosing your exact license structure (micro vs mezzobusiness vs retailer) with an eye toward on‑site consumption.mncannabiscollege+1 Working with your city (Vadnais Heights or wherever your store will be) to: Draft or influence a local ordinance explicitly allowing micro/retail on‑site consumption areas under Chapter 342.28.mn +2 Get informal feedback on your concept, floor plan, hours, and neighborhood concerns. Designing your floor plan and SOPs so they’re plug‑and‑play once OCM opens the on‑site endorsement applications.revisor.mn +2 If you share: What license type you either have or are targeting (micro vs mezzo vs retailer), and The specific city you’re planning to locate in, I can sketch a one‑page checklist tailored to your situation and even a draft floor‑plan concept for how to lay out the lounge vs retail area under Minnesota rules.